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ABSTRACT 
 To investigate the effects of maternal diet on passive transfer of immunity to the neonatal 
beef calf, and calf immune response to vaccination and immunostimulants, three experiments 
(Exp.) were completed. Results from Exp. 1 indicated that there was no effect of supplemental 
starch to cows on colostrum production, offspring birth weight, incidence of dystocia, respiratory 
acidosis, and the passive transfer of immunity.  Results from Exp. 2 indicated that both the 
needle – free injection devices (NFs) and needle and syringe (NS) initiate a haptoglobin (Hp) 
inflammatory response (P < 0.001). After injection bovine viral diarrhea virus (BVDV) type 2 
antibody titers continually declined from d 0, 7, 28, and 115 across both NS and NF treatment 
groups (P < 0.001). After secondary booster vaccination on d 115, BVDV type 2 antibody titers 
significantly increased by d 143 (P < 0.001). The use of NFs will maintain a level of immunity 
that has been seen by the use of conventional NS vaccine administration methods. In Exp. 3, 
treatments containing a modified live vaccine (MLV) antigen initiated an Hp inflammatory 
response over time (P < 0.001). Interferon gamma was not significantly different across 
treatment over time (P = 0.39); however, there was a threefold increase in treatment three over 
time.  Treatments containing a MLV BVDV antigen maintained BVDV type 2 antibodies over 
time (P <0.001).  Feed intake and feeding behavior were unaffected by the use of the vaccine 
and/or immunostimulant.   
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CHAPTER 1. LITERATURE REVIEW 
Introduction  
 The immune system protects animals against microbial invasion and is essential for life. 
Fetal calves are able to respond early in gestation to foreign invaders; however, the dams’ own 
immune system and the placenta provide additional protection to the fetal calf. The ruminant 
placenta is morphologically classified as cotyledonary and histologically classified as 
syndesmochorial (Lemley et al., 2015). The syndesmochorial placenta of the cow forms a 
syncytium between the maternal endometrium and the fetal trophectoderm; thus, separating the 
maternal and fetal blood supplies (Arthur, 1996). This separation of maternal and fetal blood 
supplies prevents the transmission of immunoglobulins in utero (Weaver et al. 2000). 
Prevention of the transfer of immunoglobulins in utero means calves are born 
agammaglobulinemic; thus, the calves have very little to no immunoglobulins in circulation 
(Weaver et al. 2000), and are characterized as being immuno-naïve. (Barrington and Parish, 
2001). Although immuno-naïve in utero, as the fetus develops so do the various innate and 
adaptive immune defenses (Barrington and Parish, 2001). By the time parturition takes place 
and the calf is born, it can respond to a variety of antigens, but still not completely as when the 
calf is fully mature (Barrington and Parish, 2001). This is due to a lack of immunological 
memory that is achieved by the immune system responding to a threat and activating the 
immune system.  
 Intake and absorption of colostral components plays a critical role in passive immune 
transfer and ultimately survival rate of the neonatal calf (Stelwagen et al., 2009). 
Colostrogenesis occurs prepartum and results in the formation of colostrum in the mammary 
gland (Stark et al., 2015). Colostrum contains a complex of cells and proteins that actively 
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protect the neonate from pathogens and other extra-uterine challenges (Bendixen et al., 2011). 
The bovine mammary gland plays an active role in regulating the concentration of various 
immunoglobulins in colostrum.  
 The passive transfer of colostral immune-proteins (PIT), specifically immunoglobulins, 
to the calf plays a critical role in short-term calf health (Smith and Little, 1922). Success of 
colostral transfer, reported by calf serum immunoglobulin concentrations, has been shown to be 
an important indicator of preweaning morbidity and mortality (Perino, 1997). Calves with 
inadequate serum IgG concentrations (<8 mg/ml) at 24 h after birth are from 3.2 to 9.5 times 
more likely to become sick and 5.4 times more likely to die before weaning compared to calves 
with adequate concentrations of serum IgG (Perino et al., 1993).  
 The passive immune transfer is critical to immediate survival of the calf, while the 
continued health of the animal is paramount to long term productivity. In livestock, the major 
causes of death preceding slaughter are due to infectious diseases (Babiuk, 2002). Bovine 
respiratory disease complex (BRDC) persists as the single most costly disease syndrome 
associated with commercial beef production in the United States. The appropriate use of 
vaccines can reduce the risk of BRDC (Urban-Chmiel and Grooms, 2012). Disease control 
requires the stimulation of the immune system in a sufficient proportion of the population or 
herd (Siegrist, 2013). Immunization is achieved by inducing protection, through stimulation of 
the adaptive immune system (Siegrist, 2013). This immunity is achieved by the maintenance of 
antigen-specific immune effectors and/or by the induction of immune memory cells that can 
reactivate if re-exposure to the antigen occurs (Siegrist, 2013). 
 This literature review will discuss: 1) the in utero development of the calf and its 
immune system; 2) the formation of colostrum in the mammary gland; 3) the digestive 
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physiology of the neonatal calf gut and the absorption of the immune components found in 
colostrum; 4) factors that affect the efficiency of absorbing the immune components of 
colostrum; 5) the immune response in relation to vaccination and its effect on prolonged calf 
health; and 6) the immune response in relation to immunostimulants and its effects on 
prolonged calf health. When possible, examples from research performed on beef cattle will be 
used.  However due to limited information and similarities observed in the mammalian immune 
systems, knowledge from across species will be included in this literature review. Following 
this literature review, the main experimental objectives of this thesis will be discussed in their 
own chapters, followed by a general discussion and considerations for future research.  
In Utero Development  
 The cow is one of the “eutherian” species, i.e. those that have placentas (Schlafer et al. 
2000). “Placenta” is taken from the Latin term meaning “flat cake” due to apparent similarity of 
the human discoid placenta to the round flat loaves of unleavened bread commonly made in 
ancient times (Schlafer et al. 2000). The ruminant placenta is morphologically classified as 
cotyledonary and histologically classified as syndesmochorial (Lemley et al., 2015). The 
syndesmochorial placenta of the cow forms a syncytium between the maternal endometrium 
and the fetal trophectoderm; thus, separating the maternal and fetal blood supplies (Arthur, 
1996). This separation of maternal and fetal blood supplies prevents the transmission 
immunoglobulins in utero (Weaver et al. 2000). The bovine placenta contains a population of 
fetal macrophages (Schlafer et al. 2000), in human medicine these phagocytes are termed 
Hofbauer cells (Benirschke and Kaufmann, 1995). These cells play an important role in utero 
fetal defenses (Schlafer et al., 2000). Fetal placenta macrophages originate from the chorionic 
mesenchyme early in gestation or from fetal bone marrow-derived macrophages (Schlafer et al., 
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2000). Prevention of immunoglobulin transfer in utero means calves are born 
agammaglobulinemic; thus, the calf has very little to no immunoglobulins in circulation 
(Weaver et al. 2000) and are characterized as being immuno-naïve (Barrington and Parish, 
2001).  
 Although immuno-naïve in utero, as the fetus develops so do the various innate and 
adaptive immune defenses (Barrington and Parish, 2001). These mechanisms can be 
characterized into those dependent on antigen recognition by antibody and or lymphocytes, 
adaptive immunity, and those that occur independent of recognition events, innate immunity 
(Barrington and Parish, 2001). The innate immune defense mechanisms include effects such as 
secreted enzymes, acids in the stomach, epithelium, and normal flora that colonize the mucosal 
surfaces once the neonate is born (Barrington and Parish, 2001). The innate immune system 
also includes the complement system and phagocytic cells, both neutrophils and macrophages 
derived from pluripotent stem cells (Tizard, 2013). Neutrophils and macrophages contribute 
minimal protection in early fetal life since they remain in their derivation sites until being 
released into the fetal blood at approximately d 130 of gestation (Banks and McGuire, 1989). 
Complement activity has been reported at approximately d 90 of gestation (Osborn et al., 1974). 
Innate immunity defense mechanisms increase in their effectiveness throughout gestation and 
though they are functional by birth, they can be suppressed by stress, malnutrition, low level 
infections, or exposure to toxins (Barrington and Parish, 2001). The adaptive immune defense 
system consists of antibodies, memory lymphocytes, and effector cells (Tizard, 2000). 
Lymphocytes, also developed from pluripotent stem cells, are initially released into the 
circulation where they later migrate to specific locations to undergo further differentiation 
(Barrington and Parish, 2001). T-lymphocytes mature in the thymus and B-lymphocytes mature 
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in the bone marrow and Peyer’s patches (Barrington and Parish, 2001). During the first 
trimester of gestation, T and B-lymphocytes move from primary lymphoid organs to populate 
the lymph nodes, spleen, and mucosal lymphoid tissues; this activity occurs independent of 
antigen exposure and stimulation (Barrington and Parish, 2001). By the time parturition takes 
place and the calf is born it can respond to a variety of antigens, but still not as completely as 
when the calf is fully mature due to a lack of immunological memory (Barrington and Parish, 
2001).  
 In addition to growth and development of the fetal immune system, fetal growth overall 
is crucial and can be affected by nutritional status of the dam. In rats, Godfrey and Barker 
(2000) demonstrated that the maternal diet can have significant long- and short-term impacts on 
offspring health. Maternal nutrition is crucial to fetal and placental development, which 
ultimately influences lifetime performance of that animal (Funston et al., 2010). Despite 
improved management techniques and extensive research on mammalian nutrition, suboptimal 
nutrition during gestation continues to be problematic for many livestock species (Wu et al., 
2004). Nutrition demand during the early phases of fetal development are critical to 
accommodate maximal placental growth, differentiation, and vascularization (Funston et al., 
2010). Normal fetal development follows an exponential pattern, such that 75% of growth in 
the bovine fetus takes place in the last 2 mo (NRC 2000; Robinson et al., 1977). Nutrient 
demands of the fetus parallel the exponential growth of the fetal tissues (NRC, 2000). By d 250, 
uterine uptake from maternal nutrient supply is 46%, 72%, and 12% for glucose, amino acids, 
and acetate, respectively (Bell, 1995). In order to meet these requirements the dam may need to 
dramatically shift basal metabolism (Bell, 1995). 
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 The protein requirement of the dam will drastically increase with the increase in amino 
acid uptake in utero. Bull et al. (1979) reported that cows maintained on diets deficient in crude 
protein produced calves that exhibited symptoms classically seen of Weak Calf Syndrome. 
Calves born to heifers that received a protein-restricted diet had decreased heat production of 
11.4% compared to calves born to dams receiving adequate protein levels in the diet (Carstens 
et al. 1987). More recent research has shown positive results for cow weight and body condition 
in calves born from cows supplemented with a protein supplement (Larson et al., 2009), as well 
as improved performance and health of offspring (Martin et al., 2007; Stalker et al., 2006; 
Larson et al., 2009). Weaning weights, both actual and adjusted, were greater in calves from 
supplemented dams (Larson et al., 2009; Kennedy et al., 2016). Heifers from protein-
supplemented dams were heavier at weaning, pre-breeding, first pregnancy, and had greater 
pregnancy rates than those from non-supplemented dams (Martin et al., 2007). Steers from 
protein-supplemented dams had increased weaning and carcass weights (Stalker et al., 2006; 
Larson et al., 2009). The carcasses from protein-supplemented dams also had greater 
intramuscular fat and increased percent choice quality grades (Larson et al., 2009). Earlier work 
by Martin et al. (2007) did not show a difference between protein- and non-supplemented dams, 
however, more recent research by Larson et al. (2009) indicates that protein-supplementation 
during late gestation did tend to affect calf birth weight. Later work by Kennedy et al. (2016) 
showed increased calf birth weight of dams supplemented protein during late gestation.     
 In addition to protein requirements of the dam and fetus; uterine uptake of glucose and 
acetate by the fetus also increases by 46% and 12% respectively (Bell, 1995). Unlike amino 
acid placental uptake, which is through active transport (Bell, 1993), glucose placental uptake 
occurs through facilitated diffusion (Stacey et al., 1978). Thus, glucose transport is dependent 
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upon the maternal – fetal plasma glucose concentration gradients and responds to changes in 
maternal plasma glucose (Bell, 1995). Ewes deprived of energy are susceptible to 
hypoglycemia during late pregnancy (Bergman, 1973), which results in a reduction in uterine 
and fetal glucose uptake (Hay et al., 1984; Leury et al., 1990). If nutrient available glucose is 
limited in ewes, most glucose available to oxidation is made up of increased catabolism of 
amino acids, at the expenditure of protein synthesis and deposition of the fetus (Lemons and 
Schreiner, 1983).  This results in reduced fetal growth associated with placental synthesis and 
excretion of urea (Lemons and Schreiner, 1983). Supplying adequate levels of starch to the dam 
during late gestation can directly supply the placental and fetal tissues with glucose and 
indirectly supply the placental and fetal tissues with amino acids. Underwood et al. (2010) saw 
improved final body weights, average daily gain (ADG), adjusted 12th rib fat thickness, and hot 
carcass weights (HCW) of calves whose dams were provided improved forage quality pastures 
during late gestation compared to dams grazing native low quality forage quality. They did not 
see any differences in birth weight and adjusted 205 d weaning weights. However; Radunz et al. 
(2012) reported that calves from corn supplemented dams had increased birth weight, 100 d 
weights, and tended to have improved weaning weights. Radunz et al. (2012) did not observe 
the improved carcass characteristics that was noted by Underwood et al. (2010). These 
differences in outcomes may be due to the differences in starch availability from pasture 
forages and corn.  
 Birth weight is commonly used as an initial reference point when regarding the 
development of an individual animal, and it represents the culmination of the most dynamic 
growth and development process in mammalian biology (Holland and Odde, 1992). At 
fertilization, the weight of the zygote is approximately 1.0 ng, by parturition, the fetal weight 
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averages 38.5 kg, which equates to a 38 trillion fold increase in weight over an average 283 d 
period (Holland and Odde, 1992). Since gestation length is relatively constant, variations in 
birth weight (BW) are the result of differences in fetal growth rate (Holland and Odde, 1992). 
Offspring born at above-average BW have an increased chance of survival compared to those 
born at below-average BW (Funston, et al., 2010). However, above-average BW may increase 
the incidence of dystocia (Laster et al., 1973), leading to increased birth asphyxia, metabolic 
and respiratory acidosis (Szenci, 1985), depressed immunoglobulin absorption (Odde, 1988), 
and an increased predisposition to disease (Roy, 1990). Offspring with below-average BW may 
lack vigor, tolerance to cold-stress (Carstens et al., 1987), resistance to infectious agents (Roy, 
1990), or the ability to overcome stresses of parturition during adaptation to extra uterine life 
(Woodward and Clark, 1959; Herschler et al., 1962). Increased BW in livestock species can be 
advantageous or detrimental depending on production environment; thus, it is critical to 
recognize the demand environment places on the animal genetics (Jenkins and Ferrell, 2006).  
Colostrogenesis  
 As previously mentioned, the syndesmochorial placenta of the cow separates the 
maternal and fetal blood supplies (Arthur, 1996); thus, preventing the transmission of 
immunoglobulins in utero and categorizing the neonatal calf as agammaglobulinemic (Weaver 
et al. 2000). Consequently, intake and absorption of colostral components plays a critical role in 
passive immune transfer and ultimately survival rate of the neonatal calf (Stelwagen et al., 
2009). Colostrogenesis occurs prepartum and results in the formation of secretory colostrum in 
the mammary gland (Stark et al., 2015). The mammary gland begins concentrating colostral 
components during the final 4-5 wk of pregnancy (Stark et al., 2015). Colostrum is a 
combination of diverse components, such as fat, lactose, vitamins, and minerals that have a high 
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quality nutritional composition (Ontsouka et al., 2003). In addition to and more important than 
the nutritional value, colostrum contains a complex of cells and proteins that actively protect the 
neonate from pathogens and other extra-uterine challenges (Bendixen et al., 2011). In colostrum 
the concentration of immunoglobulins is particularly high; in ruminants the major 
immunoglobulin class is IgG (Stelwagen et al., 2009). In addition to immunoglobulins, 
colostrum contains viable cells such as neutrophils and macrophages, which secrete numerous 
immune-related components, as well as oligosaccharides, gangliosides, acute phase proteins, 
immunomodulatory factors, ribonucleases, and a range of peptide and proteins with 
antimicrobial activity (Stelwagen et al., 2009). These immune-related components secreted by 
neutrophils and macrophages include cytokines, antimicrobial proteins and peptides, and 
reactive oxygen species (Stelwagen et al., 2009). Mammary epithelial cells also contribute to 
the host defense by secreting innate immune effector molecules such as lactoferrin, β-defensin, 
and lipopolysaccharide-binding protein (LBP) (Stelwagen et al., 2009).  
 Research on the hormonal regulation of immunoglobulin transport into colostrum has 
been investigated but remains incomplete (Wheeler et al. 2007). Smith et al. (1971) suggested 
that changing serum concentrations of estrogen and progesterone in late pregnancy exerted a 
controlling influence on the transport of IgG. Other research suggests the IgG transfer is a 
consequence of mammary gland development, which is controlled by estrogen and 
progesterone. (Lascelles and McDowell, 1974). 
 The accumulation of immunological cells and proteins enter the bovine mammary gland 
in various ways. The bovine mammary gland plays an active role in regulating the 
concentration of various immunoglobulins in colostrum, predominantly IgG and to a lesser 
extent IgA, however the mammary epithelium itself does not synthesize immunoglobulins 
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(Stelwagen et al., 2009). A small amount of the immunoglobulins enter the colostrum from the 
blood serum through the paracellular route as a result of “leaky” intercellular tight junctions 
(Lacy-Hulbert et al., 1999). The vast majority of immunoglobulins enter through a selective 
receptor-mediated intracellular route (Stelwagen et al., 2009). These immunoglobulins may be 
blood-derived or produced in situ by intramammary plasma cells (Stelwagen et al., 2009). 
Mayer et al. (2005) demonstrated the presence of a specific IgG receptor, neonatal Fc receptor 
(FcRN), in the mammary epithelial cell (MEC) that plays an active role in transporting IgG into 
the lactating bovine mammary gland. IgA found in bovine colostrum is produced by 
intramammary plasma cells (Stelwagen et al., 2009). These plasma cells move to the mammary 
gland through the blood, where their transport is mediated by chemokines (Wilson and Butcher, 
2004). The movement of IgA across the MEC is facilitated by the polymeric immunoglobulin 
receptor (pIgR) expressed in the mucosal epithelium (Apodaca et al., 1994). On the apical side 
of the MEC, pIgR is cleaved and IgA is released into the alveolar lumen along with a secretory 
component of pIgR (Apodaca et al., 1994).  
 The movement of neutrophils and macrophages into the alveolar lumen is mediated in a 
separate fashion than that seen with IgG and IgA. Serum amyloid A3 (SAA-3), a variant of the 
serum amyloid A (SAA) family, is expressed by MEC in response to pathogens and is present 
in milk and colostrum (McDonald et al., 2001). The concentration of SAA-3 is increased 200 
fold in colostrum than in later lactation milk (McDonald et al., 2001). The SAA protein has 
numerous proinflammatory actions including chemoattractant to neutrophils, monocytes, and T 
lymphocytes, causing adhesion to the MEC (Badolato et al., 1994; Xu et al., 1995; Su et al., 
1999). These findings suggest a crucial function for SAA to establish and maintain 
inflammation (He et al., 2009). The inflammatory status produced by SAA allows a continued 
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flow of neutrophils and macrophages into the alveolar lumen, which directly kill bacteria via 
phagocytosis, but also produce numerous cytokines, reactive oxygen species and antimicrobial 
peptides (Stelwagen et al., 2009). Cytokines are immunological regulatory proteins that affect a 
wide variety of cells and tissues (Tizard, 2000). Cytokines are redundant in their biological 
activities and many of them have similar effects. This has given rise to the concept of the 
cytokine network (Hirako et al., 2005). Further explanation is beyond the scope of this review. 
Reactive oxygen species are highly reactive metabolites of oxygen, including superoxide anion, 
hydroxyl radicals, and hydrogen peroxide, that are produced by active phagocytes (Abbas et al., 
2014). Reactive oxygen species are used by phagocytes, such as neutrophils and macrophages, 
to form oxyhalides that damage phagocytized bacteria and may also be released from the cells 
to promote an inflammatory response (Abbas et al., 2014).  
 The bovine MEC plays an active role in mammary gland defense and synthesis of 
lactoferrin, β-defensins, and LBP (Stelwagen et al., 2009). Lactoferrin is an iron binding 
molecule that transports iron ions; additionally, lactoferrin has a wide variety of biological 
functions (Brock, 2002). Lactoferrin provides antimicrobial activity, both bactericidal and 
fungicidal, to the mammary gland and to the neonate (Brock, 2002). The concentration of 
lactoferrin increases during most inflammatory reactions and some viral infections, and it is 
classified as an acute phase protein (APP) (Kanyshkova et al., 2001). Β-defensins are a subset 
of antimicrobial peptides that interact with the adaptive immune system, and are produced in 
response to microbial products or pro-inflammatory cytokines (Ganz and Lehrer, 1998). 
Lipopolysaccharide binding protein (LBP) is one of the most produced immune system proteins 
during infections with gram-negative bacteria (Schumann et al., 1990). The main function of 
LBP is to bind bacteria lipopolysaccharides (LPS) expressed on the cell wall of bacteria, acting 
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as a transporter for LPS and to help control LPS-dependent monocyte response (Stelwagen et 
al., 2009). 
Bovine Neonatal Digestive Tract Physiology  
 
 Nursing by the calf on the dam will cause the closure of the esophageal groove (Dirr and 
Dirksen, 1989). Closure of the esophageal grooves allows colostrum and milk to bypass the 
reticulo-rumen and enter the abomasum (Titchen, 1976). Fluid consumed by the neonatal calf 
must come into contact with the receptors located in the oropharyngeal area (Dirr and Dirksen, 
1989). Nursing by the neonate causes vagal stimulation of the afferent nerve located in the 
mouth and pharynx. This stimulation causes the lips of the esophageal groove extending from 
the cardia to the reticulo-omasal orifice to contract (Phillipson, 1970). A twisting movement of 
the lip draws the epithelium to the reticulum adjacent to it forming a tube for colostrum and 
milk to pass into the abomasum (Phillipson, 1970). Failure of the esophageal groove causes the 
colostrum or milk to flow into the reticulo-rumen (Dirr and Dirksen, 1989). If the colostrum or 
milk remains in the reticulo-rumen for a sufficient period of time, bacterial fermentation will 
take place, which can cause ruminal acidosis that can be fatal (Dirr and Dirksen, 1989). 
 The abomasum is similar to the monogastric stomach, and it is the only region in the 
gastrointestinal tract that contains secretory tissues, with fundic and pyloric regions that are 
histologically similar to the monogastric (Church, 1988). The fundic mucosa contains parietal 
cells, which secrete hydrogen chloride (HCL), peptic cells that secrete the proteolytic enzyme 
precursor pepsinogen, and mucous-secreting cells (Church, 1988). The secreted amounts of 
HCL are low at birth, although the plasma concentration of gastrin, which upregulates the 
secretion of HCL, is high (Guilloteau et al., 2009). The number of parietal cells, which release 
HCL are also very low at birth, but increases ten times during the first 72 h of life (Hill, 1956). 
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The pH of the abomasum is approximately 5.8 at birth before the first nursing and decreases to 
approximately 3.0 after 42 h (Guilloteau et al., 1985). Chief cells in the abomasum, the only 
protease producing cells found in the abomasum, secrete an inactive proteolytic enzyme 
pepsinogen (Church, 1988; Johnson, 2013). Pepsinogen is converted to the active protease 
pepsin at a pH of 2.1 (Church, 1988). The elevated pH seen in the abomasum at birth and for 
the first 24 h of life decreases proteolytic activation of pepsin (Guilloteau et al., 1983). This 
minimizes proteolytic and denaturing activity, which allows immunologic proteins and cells 
found in colostrum to move through the ruminant abomasum viably (Guilloteau et al., 1983). 
 Colostrum exits the abomasum via the pyloric valve and enters into the duodenal region 
of the small intestine. It is at the major duodenal papilla, very close to the pyloric valve in the 
small intestine, that the bile and pancreatic ducts enter (Church, 1988). At birth the pancreatic 
gland of the calf is well developed and ready to exert its exocrine function (Guilloteau et al., 
2009). In the neonatal calf, secretions of the pancreatic juice are very low at birth (Guilloteau et 
al., 2009). The secretions respond to feeding from the first day of life. The secretions take place 
during the cephalic phase, during nursing, with the elevation of plasma concentrations of 
pancreatic polypeptide (Zabielski and Naruse, 1999). However, pancreatic secretions in the 
same study were not observed during the gastric and intestinal phases (Zabielski and Naruse, 
1999). In the non-nursing neonatal calf, the exocrine pancreas secretes small amounts (about 1 
µl/kg BW x min-1) of pancreatic juice (Guilloteau et al., 2009). Pancreatic secretions steadily 
increase with age and reach 4.0 and 5.5 µL/kg BW/min-1 in 1 and 4 week old calves 
respectively (Zabielski and Naruse, 1999). Pancreatic proteases and trypsin secretions increase 
following the pancreatic juice volume patterns (Zabielski and Naruse, 1999). Bovine IgG, the 
most abundant immunoglobulin in colostrum, is most sensitive to degradation by trypsin 
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(Pineiro, 1978).  In order to combat trypsin degradation activity in the small intestine, 
colostrum contains trypsin inhibitors; colostrum has almost 100 times the level of trypsin 
inhibitors compared to conventional milk (Sandholm and Hankanen-Buzalski, 1979). The 
concentration of trypsin inhibitors in colostrum is positively related to the concentration of IgG 
in the colostrum, which for poor quality colostrum can further reduce absorption due to a 
reduced defense against the proteolytic activity of trypsin (Quigley et al., 1995). 
 The amount of immunoglobulins transported across the epithelium of the small intestine 
increases from duodenum to ileum (Jochims et al., 1994). Absorption of colostral 
immunoglobulins occurs via transport through the enterocytes by pinocytosis (Jochims et al., 
1994). The enterocytes of newborn calves seem to be non-discriminately permeable to all 
classes of immunoglobulins, as well as other proteins and macromolecules (Jochims et al., 
1994; Tizard, 2000; Mayer et al., 2002). Immunoglobulins pass through the glycocalyx on the 
apical membrane of the enterocyte towards the basolateral membrane where they are 
exocytosed into the lacteals and intestinal capillaries and enter systemic circulation through the 
thoracic duct. (Tizard, 2000; Mayer et al., 2002; Weaver et al., 2000). The non-selectivity of 
this process has been substantiated by the fact that other protein macromolecule concentrations 
and enzyme activities such as γ-glutamyltransferase (GGT) are increased after ingestion of 
colostrum (Thompson and Pauli, 1981). However, Goldstein et al. (1951) identified clathrin 
molecules on the enterocytic microvilli in the jejunum and ileum of the calf near the IgG 
molecules, which may be evidence of a receptor mediated system of transport. The presence of 
clathrin molecules implies the existence of the coated pits of vesicles (Stanley et al., 1972). 
Also, Mayer et al. (2002) determined the FcRN transporter protein is in neonatal ruminant on 
the apical side of enterocytes. In a similar fashion the specific IgG receptor FcRN in the MEC 
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transports IgG into the lactating bovine mammary gland (Mayer et al., 2005). Reber et al. 
(2006) demonstrated the movement of whole leukocytes takes place from the intestinal lumen 
through the enterocyte and into circulation. They demonstrated that cytokines Cd43 and Cd11, 
necessary for leukocyte transendothelial migration, are found in colostrum and assist in the 
migration through the enterocyte and into neonatal circulation.  
 The cessation of macromolecule absorption in the enterocyte is termed closure (Smith 
and Little, 1922). In the bovine neonate, closure of the enterocyte to colostral immune-proteins 
occurs with age at a progressively increased rate after 12 h postpartum (Stott et al., 1979a). 
Complete closure occurs at approximately 24 h postpartum when calves are not fed colostrum 
and even earlier on calves that receive colostrum shortly after birth (Stott et al., 1979b). Closure 
is caused by rapid neonatal enterocyte turn-over (Smeaton and Simpson-Morgan, 1985; 
Jochims et al., 1994). Lysosomes appear in new enterocytes at 24 h postpartum (Jochims et al., 
1994). Lysosomes are membrane-enclosed organelles that contain enzymes capable of breaking 
down all types of biological polymers (Cooper, 2000). Immune-proteins that are absorbed by 
the enterocyte will come into contact with this organelle and be degraded (Jochims et al., 1994). 
Lysosomes first appear in the duodenum, followed by the cranial and middle regions of the 
jejunum (Jochims et al., 1994). The appearance of lysosomes first in the duodenum then in the 
upper and middle regions of the jejunum could be the reason that the lower section of the 
jejunum and the ileum were seen to absorb the largest amount of immunoglobulins (Jochims et 
al., 1994). Enterocytes will continue to absorb immune-proteins.  However, the protein is 
destroyed proteolytically by the fusion of the lysosome with the vesicles containing the 
immune-proteins (Jochims et al., 1994).        
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Passive Immune Transfer and Factors Affecting its Efficiency 
 The PIT, specifically immunoglobulins, to the calf plays a critical role in short-term calf 
health (Smith and Little, 1922). Success of colostral transfer, reported by calf serum 
immunoglobulin concentrations, has been shown to be an important indicator of preweaning 
morbidity and mortality (Perino, 1997). The primary immunoglobulin found in colostrum is 
IgG and it accounts for approximately 85% of the total immunoglobulins, with IgG1 accounting 
for 80-90% of the total IgG (Larson et al., 1980). Calves with inadequate serum IgG 
concentrations (<8 mg/ml) at 24 h are from 3.2 to 9.5 times more likely to become sick and 5.4 
times more likely to die before weaning compared to calves with adequate concentrations of 
serum IgG (>16 mg/ml) (Perino et al., 1993). When calves have inadequate serum IgG 
concentrations (<8 mg/ml) a failure of passive transfer of immunity (FPT) has occurred (Perino 
et al., 1993). In general, this is due to the inability of the dam to accumulate and secrete 
immunoglobulins and/or the neonatal calf’s inability to nurse and absorb immunoglobulins in 
the bloodstream. Failure of the passive transfer of immunity itself is not a disease, it is a 
condition that predisposes the neonate to the development of infectious disease (Weaver et al., 
2000). Numerous factors can cause FPT, the two most important are calf age at colostrum 
consumption and the mass of IgG consumed (Perino, 1997). Associated with these two factors 
are dystocia, twins, sex of calf, metabolic state of calf, dam disease and vaccination history, 
dam and calf genetics, dam age, dam body condition score, dam nutrition, and dam udder 
conformation and health (Perino, 1997; Weaver et al., 2000).  
 Immunoglobulin transfer across the enterocyte is optimized in the first 4 h postpartum 
and begins to decline rapidly after 12 h postpartum (Stott et al., 1979; Bush and Staley, 1980). 
Calves fed earlier will have a significantly higher serum IgG concentration than those fed later 
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when similar concentrations are fed (Stott et al., 1979). In addition to the calf’s ability to nurse 
and absorb is the dam’s ability to accumulate and secrete immune-proteins. IgG comprises 
roughly 85% of the total immunoglobulins found in colostrum; thus, the concentration of IgG in 
colostrum has been considered the trademark for evaluating colostrum (Larson et al., 1980; 
Godden, 2008). High quality colostrum has an IgG concentration greater than 50 mg/mL 
(McGuirk and Collins, 2004). The average concentration of IgG in dairy breeds (predominantly 
Holsteins) is 32 mg/mL in dams ranging in age from 2-5 plus years (Foley and Otterby, 1978) 
and in beef breeds (predominantly Hereford and Angus) is 57.65 mg/mL in dams ranging in age 
from 2-9 plus years (Odde, 1988). This difference is due to the inverse relationship of milk 
yield and colostral IgG production (Pritchett el al., 1991). 
 Incidence of dystocia has been reported to decrease PIT (Odde, 1988; Muggli et al., 
1984). However, Stott and Reinhard (1978) did not find a dystocia effect on calf serum IgG 
concentrations when all calves were fed 1 L of colostrum. Prolonged parturition can cause the 
development of respiratory or metabolic acidosis, and calves with prolonged calving times are 
more likely to become acidotic than calves born from normal parturition (Szenci, 1983). Fetal 
asphyxia is characterized by mixed respiratory-metabolic acidosis (Bleul and Götz, 2013). The 
respiratory component of acidosis is caused by an accumulation of carbon dioxide in the fetus 
due to diminished removal by the placenta (Szenci, 1985). Metabolic acidosis in neonatal calves 
is caused by L-lactate (Bleul and Götz, 2013). L-lactate in blood plasma is the result of 
anaerobic glycolysis and is formed when pyruvate is converted by lactate dehydrogenase 
(Lagutchik et al., 1996). Carbon dioxide, a weak acid, and L-lactate, a strong acid, account for 
neonatal acidosis (Bleul and Götz, 2013). Studies have shown higher concentrations of lactate 
from calves delivered after calving assistance compared to unassisted calves (Diesch et al, 
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2004; Sorge et al., 2009; Bleul and Götz, 2013). Bleul and Götz (2013) determined duration of 
parturition had effects on pH and L-lactate but not on pCO2. Serum IgG may be reduced in 
calves that have lower blood pH and elevated pCO2 when fed the same volume of colostrum per 
kg body weight (Besser et al., 1990). Duration of metabolic acidosis exceeds that of respiratory 
acidosis, 48 and 4 h, respectively, in neonatal asphyxiated calves (Bleul and Götz, 2013). 
Conversely, Boyd (1989) showed duration of metabolic acidosis did not exceed respiratory 
acidosis, 2 and >24 h, respectively. Most research on the effects of dystocia and PIT have 
focused on respiratory acidosis, measuring pH and pCO2, and results have been confounding 
(Besser et al., 1990; Boyd, 1989; Drewry and Quigley, 1997).    
 A thorough nutrition strategy can affect cow-calf productivity in many ways; however, 
there is little evidence of a direct link between gestational cow nutrition and PIT in calves 
(Perino, 1997). Concentrations of CP in gestational cow diets generally do not have significant 
effects on colostral IgG concentrations (Olson et al., 1981; Blecha et al., 1981; Hough et al., 
1990). However, Odde (1988) did see an increase in both colostral IgG and serum IgG in 
protein restricted beef heifers. Odde (1988) noted that the effect seen in calf serum IgG was 
probably the result of all calves being fed 1 L of colostrum. Olson et al. (1981) did not see a 
significant effect of the concentrations of CP in gestational cow nutrition on serum IgG levels; 
however, similar effects were reported on colostral IgG levels and Burton et al. (1984) did see 
reduced serum IgG levels in calves from protein restricted dams. The control diet used by 
Burton et al. (1984) had dietary CP levels at 110% of NRC requirement. Research on the effect 
of starch supplementation of dams during late gestation on colostrum quantity and quality has 
been limited with varying results. Corah et al. (1975) noted an increase in the number of calves 
dying due to scours (P = 0.04) from cows that received decreased energy diets; however, 
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colostral and calf serum IgG concentrations were not quantified, so it is indefinite that calf 
mortality is due to a failure of PIT.  Ewes carrying singleton lambs and fed 1.5 times their 
metabolizable energy requirement during the last week of pregnancy produced 185% more 
colostrum than unsupplemented ewes (Banchero et al., 2007). Most research investigating the 
effects nutrition has on colostral IgG and serum IgG has focused on dietary restrictions. Further 
investigation is warranted on supplementation of CP, specific amino acids and/ or starches. 
General cow nutritional status can be visually measured with the use of BCS (Perino, 1997). 
Odde (1988) reported that first calf heifers with increased BCS was associated with increased 
serum IgG concentrations in their offspring (p = 0.03); however, BCS in cows of all ages did 
not significantly affect serum IgG concentrations (p = 0.19). Perino et al. (1995) did not see a 
relationship between BCS and serum IgG levels in the calf at 24 h after birth.  
 Age of dam is an important factor to successful PIT in beef breeds (Odde, 1988; Perino, 
1995; Muggli et al., 1984) and dairy breeds (Morin et al., 2000; Pritchett et al., 1991). In all 
studies mentioned, first-calf heifers have calves with lower serum IgG concentrations. The data 
for both dairy and beef breeds shows an increase in calf serum IgG as cow’s age increases, 
plateauing at 3 - 4 yr and beginning to drop off after 6 - 7 yr. The reduction in calf serum IgG 
was only noted in beef breeds (Odde, 1988; Muggli et al., 1984). Odde (1988) noted that 
colostral IgG concentration did not differ across age. First-calf heifers have a decreased total 
colostral volume compared to multiparous dams (Odde, 1988). 
 Udder and teat confirmation and health in beef cows are not often given consideration 
(Perino, 1997). Most research on udder and teat conformation have been conducted on dairy 
cows. In dairy cows, udders suspended closer to the floor led to increased time for calves 
seeking the teat and duration of first nursing event (Ventorp and Michanek, 1992). Similar to 
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Ventorp and Michanek (1992), Edwards (1982) noted more pendulous udders did affect the 
success of calves finding the teat and suckling. Wesselink et al. (1999) did not see significance 
of udder conformation on calves finding the teat and nursing. Ventorp and Michanek (1992) did 
not report colostral or 24 h serum IgG, thus PIT or FPT was not reported. Perino (1995) 
reported that calves born to dams with clinical mastitis any time during lactation had reduced 
serum IgG concentrations at 24 h of age; however it was not apparent if mastitis was a causative 
risk factor due to compromised colostrum quality and/or quantity or if this was associated with 
poor udder confirmation.  
 The gender of the neonatal calf has been shown to affect colostrum production and later 
lactation milk production (Joaquin et al., 2015; Hinde et al., 2014). Additionally, Joaquin et al. 
(2015) found that both total immunoglobulin concentration and colostral volume were affected 
by the sex of the neonate. Total immunoglobulin concentration was higher in dams carrying 
males than for those carrying females; however, total colostral volume was higher in dams with 
female offspring than dams with male offspring (Joaquin et al., 2015). The results of the 
previous study agree with research conducted by Hinde et al. (2014). They found that dams 
with female offspring produced 5% more milk during lactation than dams with male offspring. 
They suggested that hormones from the fetus and placenta may enter maternal circulation to 
bind to the dam’s MEC and influence functional development and subsequent milk synthesis. 
The mechanism that influences milk production may also affect colostrogenesis (Joaquin et al., 
2015). The results from the studies mentioned above were performed in dairy cattle. Kennedy et 
al. (2016) found in beef cattle that total colostral volume was greater in dams carrying female 
offspring compared to dams carrying male offspring, however; they did not see a significant 
difference of colostral IgG concentration between male and female offspring. Odde (1988) 
 21 
 
reported a higher incidence of FPT in male beef calves. This could have been due to the higher 
incidence of dystocia noted in male beef calves (Odde, 1988). Perino et al. (1995) and Filteau et 
al. (2003) included dystocia in a multivariate analysis, and did not find any variation between 
male and female serum IgG levels.   
Vaccines 
 Immunization of humans and animals against infectious diseases has been practiced for 
over 200 years (Babiuk, 2002). The experiences seen through the past two centuries have 
shown the benefits of immunization and that vaccinations are one of the most cost-effective 
methods to preventing economic losses and reducing risk of disease in livestock (Babiuk, 
2002). In livestock, the major causes of death preceding slaughter are due to infectious diseases 
(Babiuk, 2002). Bovine respiratory disease complex (BRDC) persists as the single most costly 
disease syndrome associated with commercial beef production in the United States, accounting 
for losses in 2010 of 1,055,000 animals valued at $643 million (NASS, 2011). Increased 
morbidity and mortality, decreased weight gains, decreased feed utilization, and decreased 
carcass quality account for the economic losses associated with BRDC (Edwards, 2010). 
Bovine respiratory disease complex was originally termed “shipping fever” since signs often 
occur shortly after arrival into the feedlot (Urban-Chmiel and Grooms, 2012). The morbidity 
risk of BRDC in feedlot cattle occurs in the first 45 d after arrival into the feedlot with the 
highest risk occurring in wk 1 to 3, after that morbidity declines (Buhman et al., 2000; Edwards, 
1996). Vaccination for viruses and bacteria associated with BRDC are widespread (Taylor et 
al., 2010). The viral vaccine components of BRDC consist of bovine herpesvirus type 1, also 
known as infectious bovine rhinotracheitis (IBRV), bovine viral diarrhea (BVDV), 
parainfluenza virus type 3 (PIV-3), and bovine respiratory syncytial virus (BRSV) (Urban-
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Chmiel and Grooms, 2012). The bacterial vaccine components of BRDC consists of 
Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni (Urban-Chmiel and 
Grooms, 2012). Killed and modified live vaccines (MLV) are available in different 
combinations of viral pathogens (Urban-Chmiel and Grooms, 2012). The appropriate use of 
these vaccines can reduce the risk of BRDC (Urban-Chmiel and Grooms, 2012). 
 The three most common types of vaccines used for cattle are MLV, killed, and 
genetically engineered (Tizard, 2013; Cortese, 2002). Modified live vaccines contain living 
bacterial or viral organisms that are typically collected from field disease cases and then grown 
and passed through host cells or media for virus and bacteria, respectively, to attenuate the 
pathogen (Cortese, 2002). Each growth cycle represents a passage, and the modified pathogen 
is then administered back into the animal to determine its virulence (Cortese, 2002). After 
several passages, the pathogen loses virulence and can no longer cause disease in the specific 
species, and is then tested to confer immunity (Cortese, 2002). The final vaccines are passed a 
number of times beyond virulence in order to reduce the risk of reverting back to a virulent state 
(Cortese, 2002). Killed vaccines use a pathogen isolated from a disease outbreak, grown in a 
media, and then chemically or physically killed (Cortese, 2002). The inactivation of the 
pathogen is achieved using chemicals or ultraviolet rays (Cortese, 2002). A concern using this 
type of vaccine is that heat inactivation may degrade important epitopes needed for a proper 
immune response (Cortese, 2002). To improve efficacy and achieve an effective immune 
response in killed vaccines, adjuvant is added to heighten the immune response (Cortese, 2002). 
Genetically engineered vaccines have been altered through a mutation that results in a 
bacterium or virus with altered virulence or growth characteristics (Cortese, 2002). Genetically 
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engineered vaccines have been engineered to delete a gene and cause an immune response 
deficient in specific antibody responses (Cortese, 2002).  
 The term adjuvant is defined as a substance that, when used in combination with an 
antigen, enhances the immune response beyond those elicited by the antigen alone (Iain et al., 
1993). Iain et al. (1993) defined four general ways in which adjuvants promote an immune 
response. First, adjuvants maintain a depot of antigen at the site of injection. Second, adjuvants 
promote accumulation of immunoreactive cells at the site of injection and also into the draining 
lymph nodes. Third, adjuvants modify the activities of cells that generate, promote, and 
maintain the immune response. Fourth, adjuvants can modify the presentation of antigen to the 
immune system. The most common adjuvants used in veterinary medicine are aluminum 
hydroxide and oil and water micelles (Ian et al., 1993). The effects of an aluminum adjuvant 
depends on the adsorption of antigen on the surface of the precipitate (Hansen et al., 2007). The 
greater the adsorption the more effective the adjuvant, allowing more antigen in the same 
volume of solution (Hansen et al., 2007). This adsorption depends on the concentrations of the 
adjuvant and the pH of the solution (Seeber et al., 1991). At high concentrations of adjuvant 
and lower pH more adsorption will take place; however, at pH below 6.0 and higher 
concentration of adjuvant, pain and tissue irritation are produced at the injection site (Makimura 
and Suzuki, 1982). 
 Vaccines used specifically against IBR are classified into five types: parental 
administered MLV vaccines, chemically altered live virus temperature sensitive vaccines, 
inactivated viral vaccines, combination and inactivated viral vaccines, and MLV intranasal 
vaccines (Fulton, 2002). MLV parental vaccines are attenuated by multiple passages in a 
cellular culture that retain the ability to replicate in a vaccinated animal, possibly causing 
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viremia (Fulton, 2002). MLV vaccines stimulate a rapid immune response and generally one 
dose is needed to stimulate protective immunity (Sutton, 1980; Fulton, 2002). One dose will 
stimulate an adequate immune response, which varies in length depending on the form of 
disease challenge (Fulton, 2002). Long term immunity, shown by antibody and cell-mediated 
response is detectible after an MLV vaccine is administered (Fulton, 2002). MLV intranasal 
vaccines can be divided into two attenuation processes, those that are modified by cell culture 
and those modified by treatment so that they are temperature sensitive (Todd et al., 1972; 
Fulton 2002). MLV intranasal vaccines stimulate protection with one dose and induce an initial 
rapid onset of protection, possibly through interferon-γ found in nasal secretions (Todd et al., 
1972). 
 The majority of vaccines administered to cattle are parenteral, either intramuscular or 
subcutaneous, using a needle and syringe (Babiuk et al., 2018). There are potential drawbacks 
to this vaccine delivery method. Improper handling of needles can result in accidental injury to 
the individual operator as well as the animal receiving vaccine (Weese and Jack, 2008). There is 
also risk of needle fragments may break off during injection and remain in the muscle of the 
animal to slaughter (van Drunen Little-van den Hurk, 2006). Additionally, blood – born 
infectious agents such as bovine leucosis and anaplasmosis as well as organisms on the skin can 
be transmitted between animals if one needle is used to inject multiple animals (Hollis et al., 
2005; Reinbold et al., 2010). These concerns have led to the design of alternative vaccination 
techniques, including the use of needle – free injection devices (NFs) (Rey et al., 2013). As 
previously mentioned, the use of intranasal vaccines would also be an alternative to parenteral 
vaccination; however, those vaccines are specifically formulated to be administered via 
intranasal route. The use of parenteral vaccines administered via intranasal route would be off 
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label use and will not be discussed. Needle – free injection devices use compressed gas, 
typically CO2 or N2, at pressures ranging from 310.3 – 448.2 kPa (Rey et al., 2015). Upon 
triggering the device, the desired volume of vaccine is forced through a small orifice which 
forms a high pressure stream that can penetrate the skin and deposit the vaccine into the desired 
tissue (Mousel et al., 2008). This vaccination technique removes the issues observed with 
needles, helps reduce disease transfer, and reduces vaccination time (Chase et al., 2008; 
Reinbold et al., 2010; Mousel et al., 2008). This vaccination technique has been shown to elicit 
serological immune responses in cattle to Mannheimia haemolytica, IBRV, and BVDV (Hollis 
et al., 2005; Rey et al., 2013). Rey et al. (2013) did note that there were significantly higher 
numbers of injection site reactions over time in calves that received vaccination with the NFs. 
Rey et al. (2013) observation of this phenomena was measured qualitatively and quantitative 
measure of injection site reactions may be more appropriate. A novel tool to quantitatively 
measure injection sight reactivity may be with the use of infrared thermography (IRT) 
(Hoffman et al., 2018). Hoffman et al. (2018) used IRT technology to effectively measure 
injection site reactions in patients that received the influenza vaccine. In dairy cattle, IRT has 
been used to examine inflammation, infections, and lameness associated with digital dermatitis 
(Alaaod and Buscher, 2012; Harris – Bridge et al., 2018).              
 Disease control or elimination requires the stimulation of the immune system in a 
sufficient proportion of the population or herd (Siegrist, 2013). Immunization is achieved by 
inducing protection, as a result of stimulating the adaptive immune system (Siegrist, 2013). 
This immunity is achieved by the maintenance of antigen-specific immune effectors and/or by 
the induction of immune memory cells that can reactivate if re-exposure to the antigen occurs 
(Siegrist, 2013). Antigen-specific immune effectors are antibodies produced by B lymphocytes 
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that are able to bind to a specific toxin or pathogen (Cooper and Newmerow, 1984). Other 
potential effectors are cytotoxic CD8+ T lymphocytes (CTL) that may limit the spread of 
infectious antigens by recognizing and killing infected cells as well as secreting antiviral 
cytokines (Siegrist, 2013). The proliferation and maintenance of B lymphocyte and CTL 
response is supported by growth factors and signals from CD4+ T helper lymphocytes (Th) 
(Siegrist, 2013). All of these immune effector cells are controlled by regulatory T cells (Treg), 
involved in immune tolerance (Bacchetta et al., 2005). Most antigens and vaccines trigger a B 
and T cell response; however, killed vaccines mostly mediate protection through the stimulation 
of B lymphocytes secreting highly specific IgG serum antibodies (Siegrist, 2013). These 
antigen specific antibodies have been shown to confirm vaccine-induced protection against 
numerous diseases (Casadevall, 2004).  
Innate and Adaptive Immune Response 
 The body is equipped with multiple levels of defenses; thus, an organism that breaks 
through the first line of defense is confronted with a second, higher barrier and so forth (Tizard, 
2013). The first line of defense are physical barriers to invasion (Tizard, 2013). Intact skin 
provides an effective barrier to invasion; however, insults to the skin such as scratches, 
incisions, microscopic abrasions, burns, and even insect bites may allow microbes to invade 
(Tizard, 2013). Other body surfaces, such as the mucosal linings of the respiratory and 
gastrointestinal tracts can act as physical barriers as well (Tizard, 2013). Physical defenses 
include coughing, sneezing, and mucous flow of the respiratory tract and vomiting and diarrhea 
(Tizard, 2013). In addition to physical defenses, there is a large population of commensal 
bacteria on the skin and in the gastrointestinal tract that can outcompete poorly adapted 
pathogenic organisms (Tizard, 2013). 
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 To elicit a vaccine response, a vaccine must provide enough danger signals from the 
antigen, typically paired with an adjuvant, to trigger the inflammatory reaction that is mediated 
by cells of the innate immune system (Hoebe et al., 2004). Upon injection of vaccine antigens, 
an acute phase inflammation develops within minutes (Tizard, 2013). Upon injection of an 
antigen, broken cells release molecules known as damage-associated molecular patterns 
(DAMPs) that trigger the release of cytokines, chemokines, and enzymes from sentinel cells 
(Tizard, 2013). The antigens also provide pathogen-associated molecular patterns (PAMPs) that 
trigger sentinel cell response (Tizard, 2013). The swelling at the sight of injection causes 
sensory nerves to release bioactive peptides (Tizard, 2013). The complex mixture of molecules 
attracts defensive white blood cells and increases blood flow to the sight of injection. Sentinel 
cells, such as macrophages, neutrophils, and dendritic cells located near the site of injection are 
active when DAMPs and PAMPs bind to their pattern-recognition receptors (PRRs) located on 
the cell surface of the sentinel cells (Tizard, 2013). This causes the sentinel cells to synthesize 
and secrete a mixture of molecules that trigger inflammation and initiates the first steps of the 
adaptive immune system (Tizard, 2013). The three major cytokines secreted by sentinel cells 
include tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6) (Tizard, 
2013). 
 The release of TNF-α, IL-1, and IL-6 increases protein synthesis, specifically APPs 
(Tizard, 2013). APP are a group of blood proteins that change in concentration when an animal 
is subjected to external or internal challenges, such as infection, inflammation, and stress 
(Murata et al., 2004). One of the most prominent APP found in beef cattle is haptoglobin (Hp) 
(Alsemgeest et al., 1994). Haptoglobin concentrations in healthy cattle are often undetected, but 
during an acute phase response bovine Hp can increase 50-100 times (Conner et al., 1988). 
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However, Hp concentrations observed post vaccination with killed clostridial 7 – way bacterin 
toxoids or BRDC 5 – way MLV viral vaccines with a Mannheimia haemolytica toxoid have 
been closer to 4 – 7 fold increases post injection (Stokka et al., 1994; Gaspers et al., 2018). Hp 
binds to free hemoglobin (Hb) in the plasma and reduces the oxidative damage associated with 
hemolysis (Yang et al., 2003). The Hp-Hb complex is recognized by receptors on macrophages 
and phagocytized (Schear et al., 2002). This action prevents bacteria from utilizing iron and 
thus prevents bacteria from proliferating (Idoate et al., 2015). Haptoglobin also plays a key role 
in the recruitment of neutrophils in the early phase of inflammation (Riollet et al., 2000). Hp 
concentrations will increase with both bacterial and viral infections (Schroedl et al., 2001; 
Ganheim et al., 2003; Heegaard et al., 2000; Idoate et al., 2015), and Hp can be used as a tool to 
measure respiratory disease in feedlot conditions (Idoate et al., 2015).  
  The triggering of inflammation by cytokines, and the mobilization of phagocytic cells 
such as neutrophils and macrophages contributes to the rapid destruction of foreign microbes 
(Tizard, 2013). Inflammation and the actions of the innate immune system may be sufficient to 
protect the body, but it cannot be guaranteed to provide complete resistance to infection, or 
assist the body to learn from the experience (Tizard, 2013). This limitation of the innate 
immune response is the advantage of the adaptive immune response (Tizard, 2013). Dendritic 
cells are the link between the innate and adaptive immune system. Dendritic cells act as sentinel 
cells and activate the innate defenses when they first encounter foreign antigen, they can 
process antigen and initiate the adaptive immune system. They regulate adaptive immunity by 
determining whether an antigen will trigger an antibody-mediated and or cell-mediated 
response (Tizard, 2013). Dendritic cells process and then present foreign protein antigen to T 
cells (Tizard, 2013). Immature dendritic cells patrol throughout the body as sentinel cells 
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(Siegrist, 2013). When exposed to an antigen, dendritic cells undergo a maturation process, 
modulating specific surface receptors and migrate towards the lymphatic system, in secondary 
lymph nodes (Siegrist, 2013). The central role of mature dendritic cells, in response to a 
vaccine, is to provide antigen-specific and costimulatory signals to activate naïve T cells 
(Palucka et al., 2005).  
 Dendritic cells and T cells that have been upregulated by antigen exposure migrate 
towards secondary lymphoid tissues, including lymph nodes, spleen, Peyer’s patches and 
mucosal associated lymphoid tissue (Siegrist, 2013). These cells up-regulate specific surface 
molecules that provide B cell activating signals (Siegrist, 2013). T cells help drive B cell 
differentiation into immunoglobulin secreting plasma cells that can produce low affinity 
germline antibodies (Maclennan et al., 2003). When exposed to an antigen, dendritic cells 
undergo a maturation process, modulating specific surface receptors and migrate towards the 
lymphatic system, in secondary lymph nodes (Siegrist, 2013). Phagocytosed antigen is loaded 
onto the MHC class II molecules and presented to T cells (Tizard, 2013). The central role of 
dendritic cells, in response to a vaccine, is to provide antigen-specific and costimulatory signals 
to activate naïve T cells (Palucka et al., 2005).  
 Dendritic cells and CD4+ helper T cells that have been upregulated by antigen exposure 
migrate towards secondary lymphoid tissues, including lymph nodes, spleen, Peyer’s patches 
and mucosal associated lymphoid tissue (Siegrist, 2013). These cells up-regulate specific 
surface molecules that provide B cell activating signals (Siegrist, 2013). CD4+ T cell help 
drives B cell differentiation into immunoglobulin secreting plasma cells that can produce low 
affinity germline antibodies, termed the extrafollicular reaction. (Maclennan et al., 2003). 
During B cell differentiation, immunoglobulin class switching from IgM towards IgG, IgA, or 
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IgE occurs with the upregulation of activation-induced deaminase enzyme (Siegrist, 2014). 
CD4+ T cells exert helper functions during the extrafollicular pathway, and engagement on B 
cells skew class-switch recombination into particular immunoglobulin classes and subclasses 
(Siegrist, 2013). Antigen specific B cells that receive sufficient help from antigen specific T 
cells proliferate in structures known as germinal centers, where differentiation into plasma cells 
takes place (Siegrist, 2013). This stimulation of the germinal centers as a few B cells upregulate 
and migrate towards B cell follicles, due to the attraction follicular dendritic cells (Siegrist, 
2013). Follicular dendritic cells play a key role in the B cell response, they attract antigen 
specific B and T cells as well as retain antigen for extended periods of time (Siegrist, 2013). 
This time allows for a massive proliferation of the antigen specific B cells, which results in the 
large production of antibodies with increased antigen binding affinity (Siegrist, 2013).  
 B cells process vaccine antigen into small peptides that are displayed on the MHC class 
II, in a similar fashion to dendritic cells (Siegrist, 2013). The MHC-peptide complex is 
displayed on their surface and binds to a subset of CD4+ T cells, follicular helper T cells 
(Siegrist, 2013). These follicular helper T cells have different sets of chemokine receptors, 
transcription factors, surface markers, and interleukins that are uniquely equipped to provide the 
most efficient B cell help through a series of coststimulatory molecules (Vinuesa et al., 2005). 
The interactions between antigen-specific germinal center B cells, antigen bearing follicular 
dendritic cells, and follicular helper T cells results in the production of B cells with the highest 
level of antigen-specific affinity (Siegrist, 2013). This combination provides signals necessary 
for the differentiation of germinal center B cells either towards plasma secreting specific 
antibodies or towards memory B cells (Siegrist, 2013). Antigen specific antibodies have been 
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formally demonstrated as conferring vaccine-induced protection against many disease, and the 
production of memory B cells allows for the long term disease protection (Casadevall, 2004). 
Immunostimulants  
 As previously mentioned, BRDC persists as the single most costly disease syndrome 
associated with commercial beef production in the United States (NASS, 2011). Bovine 
respiratory disease complex is a leading cause of morbidity and mortality to the cattle industry 
worldwide (Ilg, 2017). In addition to vaccination for the bacterial and viral components to 
reduce the incidence of BRDC, the prophylactic use of antibiotics has been commonly used in 
United States beef production to control BRDC (Panciero and Confer, 2010; Murray et al., 
2016). With increasing public concerns about widespread use of antimicrobials and 
governmental policy regarding the use of antimicrobials, alternative preventative treatments 
have been investigated (Ilg, 2017). Activation of specific areas of the immune system in cattle 
has been considered as a potential mechanism and area of research (Ackermann et al., 2010). 
Administration of an exogenous substance that has the ability to augment and/or stimulate 
certain immune responses may have the ability to increase disease resistance (Blecha, 1988). 
Substances that exert these functions are known as immunostimulants (Blecha, 2001). The 
ability to enhance or initiate an immune response to benefit the animal and thus the production 
efficiency is the goal of immunostimulation in food producing animals (Hudson, 2017). This 
concept has raised interest in the beef industry as a potential novel preventative measure that 
may reduce antimicrobial use (Hudson, 2017). There are a limited number of 
immunostimulatory products that have been licensed by the United States Department of 
Agriculture for use in food animals and few have achieved Food and Drug Administration 
approval (Huenefeld, 1988; Blecha, 2001).  
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 The first, and only, immunostimulant on the market approved for aiding in the treatment 
of BRDC in beef cattle is Zelnate (Ilg, 2017).  Research completed by Bayer (2014) showed a 
reduction in lung lesions and mortality associated with BRDC with the use of Zelnate. Zelnate 
is a plasmid DNA rich in non – methylated cysteine and guanine (CpG) motifs that is encased 
in a cationic liposome shell (Ilg, 2017). Zelnate is indicated for use to aid in treatment of BRDC 
caused by Mannheimia haemolytica in cattle 4 mo of age or older, when administered at the 
time of or within 24 h of a perceived stressful event (Nickell et al., 2016). Ilg (2017) researched 
Zelnate’s potential mechanism of action by investigating cellular DNA recognition pathways in 
cell culture using knockout human and mouse cell lines and reporter gene assays. Ilg (2017) 
reported that Zelnate, despite being rich in CpG islands, did not activate toll like receptor 9 
(TLR9) and the downstream proinflammatory nuclear factor kappa – light – chain – enhancers 
of activated B cells (NFКB) pathway. Ilg (2017) did report that Zelnate did initiate the 
interferon regulatory transcript factor 3 (IRF3) pathway, known to lead to a strong type I 
interferon response. Rogers et al. (2017) evaluated health outcomes of at risk heifers for the first 
60 d upon arrival to the feedlot. Rogers et al., (2017) did not report differences among treatment 
groups on the incidence of heifers treated for respiratory disease; however, the inclusion of 
Zelnate did reduce the percentage of BRDC incidence as well as overall mortality by d 60. 
Roger et al. (2017) reduced morality results correspond with the results reported by Bayer 
(2014), which may suggest that the DNA immunostimulant has the potential to positively affect 
survivability and health outcomes of high risk feedlot calves. 
Objectives              
 To: 1) determine the effects of starch supplementation to mid – and late – gestating beef 
cows on colostrum production, offspring birth weight, incidence of dystocia, respiratory 
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acidosis, and the passive transfer of immunity; 2) determine the effects of maternal starch 
supplementation and vaccination strategies on the serologic immune response in calves at 
turnout; and 3) determine the serologic immune response of vaccination protocols and 
immunostimulants for bovine respiratory disease complex on feeding behavior and feedlot 
performance in previously vaccinated, weaned, backgrounding steers.  
Literature Cited 
Abbas, A. K., A. H. Lichtman, and S. Pillai. 2014. Innate immunity. In: Abbas, A. K., A. H. 
Lichtman, and S. Pillai, editors, Basic immunology: functions and disorders of the 
immune system. Elsevier Saunders, Philadelphia, PA. p. 23-48. 
Ackermann, M. R., R. Derscheid, and J. A. Roth. Innate immunology of bovine respiratory 
disease. Vet. Clin. North Am. Food Anim. Prac. 26:215-228.  
Alsaaod M. and W. Buscher. 2012. Detection of hoof lesions using digital infrared 
thermography in dairy cows. J. Dairy Sci. 95:735-742.  
Alsemgeest, S. P. M., H. C. Lalsbeek, T. H. Wensing, J. P. Koeman, A. M. Van Ederen, and E. 
Gruys. 1994. Concentrations of serum amyloid-A (SAA) and haptoglobin (Hp) as 
parameters of inflammatory diseases in cattle. Vet. Quart. 16:21-23.  
Arthur, G. H. 1996. The development of the conceptus. In: Arthur, G. H., D. E. Nokes, H. 
Pearson, and T. J. Parkinson, editors, Pregnancy and parturition in veterinary 
reproduction and obstetrics, 7th ed. WB Saunders, Philadelphia, PA. p. 51-109.  
Apodaca, G., L. A. Katz, and K. E. Mostov. 1994. Receptor mediated trancytosis of IgA in 
MDCK cells is via apical recycling endosomes. J. Cell. Biol. 125:67-86.  
Babiuk, L. A. 2002. Vaccinations: a management tool in veterinary medicine. Vet. J. 64:188-
201. 
 34 
 
Babiuk, L. A., G. L. Stokka, and J. J. Gaspers. 2017. Vaccination of animals (version 2.0) In: 
Embryonic Encyclopedia of Life Sciences. Nature Publishing Group. London, UK. 
http://www.els.net/WileyCDA/ElsArticle/refId-a0000962.html 
Bacchetta, R., S. Gregori, and M. G. Roncarolo. 2005. CD4+ regulatory T cells: mechanism of 
induction and effector function. Autoimmun. Rev. 4:491-496.  
Badolato, R., J. M. Wang, W. J. Murphy, A. R. Lloyd, D. F. Michiel, L. L. Bausserman, D. J. 
Kelvin, and J. J. Oppeheim. 1994. Serium amyloid A is a chemoattractant induction of 
migration, adhesion and tissue inflammation of monocytes and polymorphonuclear 
leukocytes. J. Exp. Med. 180:203-209. 
Banchero, G. E., G. Quintans, A. Vazquez, F. Gigena, A. La Manna, D. R. Lindsay, and J. T. B. 
Milton. 2007. Effects of supplementation of ewes with barley or maize during the last 
week of pregnancy on colostrum production. Animal 1:625-630.  
Banks, K. L., and T. C. McGuire. 1989. Neonatal immunology. In: R. E. W. Halliwell and N. T. 
Gorman, editors, Veterinary clinical immunology. Saunders, Philadelphia, PA. p. 193-
204. 
Barrington, G.M. and S. M. Parish. 2001. Bovine neonatal immunology. Vet. Clin. North Am. 
Food Anim. Pract. 3:463-476.   
Bayer. 2014. Label: DNA Immunostimulant Zelnate. Accessed 10 October 2018 at 
https://www.zelnate.com/static/documents/Zelnate_instructions-for_use.pdf 
Bell, A. W. 1995. Regulation of organic nutrient metabolism during transition from late 
pregnancy to early lactation. J. Anim. Sci. 73:2804-2819.  
 35 
 
Bell, A. W. 1993. Pregnancy and fetal metabolism. In: J. M. Forbes and J. France (Ed.) 
Quantitative aspects of ruminant digestion and metabolism. p. 405. CAB International, 
Oxford, U. K.  
Bendixen, E., M. Danielson, K. Hollung, E. Gianazza, and I. Miller. 2011. Farm animal 
proteomics: a review. J. Proteomics. 74:282-293. doi:10.1016/j.jprot.2010.11.005.  
Benirschke K. and P. Kaufmann. 1993. Pathology of the human placenta 3rd ed. Spring Verlag, 
NY. p. 84-92.  
Bergman, E. N. 1973. Glucose metabolism in ruminants as related to hypoglycemia and ketosis. 
Cornell Vet. 63:341.  
Besser, T. E., O. Szenci, and C. C. Gay. 1990. Decreased colostral immunoglobulin absorption 
in calves with postnatal respiratory acidosis. JAVMA. 196:1239-1243.   
Blecha, F., R. C. Bull, D. P. Olson, R. H. Ross, and S. Curtis. 1981. Effects of prepartum 
protein restriction in the beef cow on immunoglobulins in blood and colostral whey and 
subsequent immunoglobulin absorption by the neonatal calf. J. Anim. Sci. 53:1174-
1180.  
Blecha, F. 1988. Immunomodulation: a means of disease prevention in stressed livestock. J. 
Anim. Sci. 66(8):2084-2090. 
Blecha, F. 2001. Immunomodulators for prevention and treatment of infectious diseases in 
food-producing animals. Vet. Clin. of North Am. Food Anim. Prac. 17(3):621-633. 
Bleul, U. and E. Götz. 2013. The effects of lactic acidosis on the generation and compensation 
of mixed respiratory-metabolic acidosis in neonatal calves. Vet. Rec. 172:528. 
doi:10.1136/vr.101192. 
 36 
 
Boyd, J. W. 1989. Relationship between acid-base balance, serum composition and colostrum 
absorption in newborn calves. Br. Vet. 145:249-256.  
Brock, J. H. 2002. The physiology of lactoferrin. Biochem. Cell Biol. 80:1-6.   
Buhman, M. J., L. J. Perino, M. L. Galyean, T. E. Wittum, T. H. Montgomery, and R. S. 
Swingle. 2000. Association between changes in eating and drinking behaviors and 
respiratory tract disease in newly arrived calves at a feedlot. Am. J. Vet. Res. 61:1163-
1168. 
Bull, R. C., D. P. Olson, S. Curtis, and R. H. Ross. 1979. Effects of prepartum protein nutrition 
and birth weight on basal metabolism in bovine neonates. J. Anim. Sci. 41:819-824. 
Burton, J. H., A. A. Hosein, D. G. Grieve, and B. N. Wilkie. 1984. Immunoglobulin absorption 
in calves as influenced by dietary protein intakes of their dams. Can. J. Anim. Sci. 
64:185-185. 
Bush, L. J. and T. E. Staley. 1980. Absorption of colostral immunoglobulins in newborn calves. 
J. Dairy Sci. 63:672-680. 
Carstens, G. E., D. E. Johnson, M. D. Holland, and K. G. Odde. 1987. Effects of prepartum 
protein nutrition and birth weight on basal metabolism in bovine neonates. J. Anim. Sci. 
65:745-751. 
Casadevall A., 2004. The methodology for determining the efficacy of antibody-mediated 
immunity. J. Immunol. Methods. 291:1-10.  
Chase, C.C.L., S. Daniels, R. Garcia, F. Milward, and T. Nation. 2008. Needle-free injection 
technology in swine: Progress toward vaccine efficacy and pork quality. J. of Swine 
Health and Prod. 16:254–261. 
 37 
 
Church, D. C. 1988. The Ruminant Animal Digestive Physiology and Nutrition. Waveland 
Press Inc. Prospect Heights, Il. 
Conner, J. G., P.D. Eckersal, A. Wiseman, T. C. Aitchison, and T. A. Douglas. 1988. Bovine 
acute phase response following turpentine injection. Res. Vet. Sci. 44:82-88. 
Cooper, G.M. 2000. Lysosomes In: G. M. Cooper, editor, The cell: a molecular approach. 2nd 
ed. Sinauer Associates, Sunderland, MA.  
Copper, N. R. and G. R. Nemerow. 1984. The role of antibody and complement in control of 
viral infections. J. Invest. Dermatol. 83:121-127. 
Corah L. R., T. G. Dunn, and C. C. Kaltenbach. 1975. Influence of prepartum nutrition on the 
reproductive performance of beef females and the performance of their progeny. J. 
Anim. Sci. 41(3):819-824.  
Cortese, V. S. 2002. Bovine vaccines and herd vaccination programs. In: B. P. Smith, editor, 
Large animal internal medicine. Mosby Inc. St. Louis, MO. p. 1403-1411. 
Diesch, T. J., D. J. Mellor, K. J. Stafford, and R. N. Ward. 2004. The physiological and 
physical status of single calves at birth in a dairy herd in New Zealand. N. Z. Vet. J. 52: 
250-255.  
Dirr, L. and G. Dirksen. 1989. Dysfunction of the esophageal groove, “ruminal drinking,” as a 
complication of neonatal diarrhea in the calf. Tierarztl Prax. 17:353-358.  
Drewry, J. J. and J. D. Quigley. 1997. Effects of respiratory acidosis on apparent efficiency of 
IgG absorption in calves. J. Dairy Sci. 80:143(abstract).  
East, I. J., R. L. Kerlin, K. Altmann, and D. L. Watson. 1993. Adjuvants for new veterinary 
vaccines. In: R. Pandey, S. Hoglund, and G. Prasad, editors, Veterinary vaccines. 
Springer-Verlag New York Inc. New York, NY. p. 1-28. 
 38 
 
Edwards, A. J. 1996. Respiratory diseases of feedlot cattle in the central USA. Bovine Pract. 
30:5-7.  
Edwards, S. A. 1982. Factors affecting the time to first suckling in dairy calves. Anim. Produc. 
34:339-346. 
Edwards, T. A. 2010. Control methods for bovine respiratory disease for feedlot cattle. Vet. 
Clin. N. Am-Food An. 26(2)-273-284.  
Filteau, V., E. Bouchard, G. Fecteau, L. Dutil, and D. DuTremblay. 2003. Health status and risk 
factors associated with failure of passive transfer of immunity in newborn beef calves in 
Québec. Can. Vet. J. 44(11):907-913.  
Foley, J. A. and D. E. Otterby. 1978. Availability, storage, treatment, composition, and feeding 
value of surplus colostrum: a review. 61:1033-1060.  
Fulton, R. W. 2002. Bovine respiratory disease vaccines. In: B. P. Smith, editor, Large animal 
internal medicine. Mosby Inc. St. Louis, MO. p. 1411-1414. 
Funston R. N., D. M. Larson, and K. A. Vonnahme. 2010. Effects of maternal nutrition on 
conceptus growth and offspring performance: implications for beef cattle production. J. 
Anim. Sci. 88:E205-E215. doi:10.2527/jas.2009-2351. 
Ganheim, C., C. Hulten, U. Carlsson, H. Kindahl, R. Niskanen, and K. P. Walker. 2003. The 
acute phase response in calves experimentally infected with bovine viral diarrhea virus 
and/ or Manheimia heamolytica. J. Vet. Med. Ser. 50:183-190.  
Ganz, T. and R. I. Leher. 1998. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 
10:41-44.  
Gaspers, J. J., K. C. Swanson, and G. L. Stokka. 2018. Evaluation of serological immune 
response to modified live IBRV, BVDV, BRSV, PI3V, and Mannheimia haemolytica 
 39 
 
vaccination protocols on the feedlot performance of weaned calves. 2018. Bovine. Prac. 
Under Review.  
Godden, S. 2008. Colostrum management for dairy calves. Vet. Clin. North Am.: Food An. 
Prac. 24:19-39. 
Godfrey, K. M. and D. J. Barker. 2000. Fetal nutrition and adult disease. Am. J. Clin. Nutr. 
71:1344S-1352S.  
Goldstein, J. L., R. G. W. Anderson, and M. S. Brown. 1951. Coated pits, coated vesicles, and 
receptor-mediated endocytosis. Nature. 167:561-562.  
Guilloteau, P., R. Zabielski, and J. W. Blum. 2009. Gastrointestinal tract and digestion in the 
young ruminant: ontogenesis, adaptions, consequences and manipulations. J. Physiol. 
Pharmacol. 60:37-46.   
Guilloteau, P., T. Corring, R. Toullee, and R. Guilhermet. 1985. Enzyme potentialities of the 
abomasum and pancreas of the calf II: effect of weaning and feeding and liquid 
supplement to ruminant animals. Reprod. Nutr, Dev. 25:481-493.  
Guilloteau, P., T. Corring, and P. Garnot. 1983. Effect of age and weaning on enzyme activities 
of abomasum and pancreas of the lamb. J. Dairy Sci. 66:2373-2385.  
Hansen, B., A. Sokolovska, H. HogenEsch, and S. L. Hem. 2007. Relationship between the 
strength of antigen adsorption to an aluminum-containing adjuvant and the immune 
response. Vaccine. 25:6618-6624. doi:10.1016/j.vaccine.2007.06.049. 
Harris-Bridge, G., L. Young, I. Handel, M. Farish, C. Mason, M. A. Mitchell, and M. J. 
Haskell. 2018. The use of infrared thermography for detecting digital dermatitis in dairy 
cattle: What is the best measure of temperature and foot location to use? Vet. J. 237:26-
33.  
 40 
 
Hay, W. W., Jr., W. Sparks, R. B. Wilkening, F. C. Battaglia, and G. Meschia. 1984. Fetal 
glucose uptake and utilization as functions of maternal; glucose concentration. Am. J. 
Physiol. 246: E237.  
He, R. L., J. Zhou, C. Z. Hanson, J. Chen, N. Cheng, and R. D. Ye. 2009. Serum amyloid A 
induces G-CSF expression and neutrophil via toll-like receptor 2. Blood. 113:429-437.  
Heegaard, P. M. H., D. L. Godson, M. J. M. Toussaint, K. Tjornehoj, L. E. Larsena, B. Viuff, 
and L. Ronsholt. 2000. The acute phase response of haptoglobin and serum amyloid A 
(SAA) in cattle undergoing experimental infection with bovine respiratory syncytial 
virus. Vet. Immunol. Immunopathol. 77:151-159.  
Herschler, M. S., N. S. Fechheimer, and L. O. Gilmore. 1962. Congenital abnormalities in 
cattle: their association with heredity and environmental factors. J. Dairy Sci. 45:1493-
1499.  
Hill, K. J. 1956. Gastric development and antibody transference in the lamb with some 
observations on the rat and guinea-pig. J. Exp. Physiol. 41:421-432.  
Hinde, K., A. J. Carpenter, J. S. Clay, and B. J. Bradfors. 2014. Holsteins favor heifers, not 
bulls: biased milk production programmed during pregnancy as a function of fetal sex. 
Plos. 9(2):e86169. doi:10.137/journal.pone.0086169.  
Hirako, T., K. Hisaeda, K. Izumi, T. Kurosawa, K. Hagiwara, R. Kirisawa, and H. Iwai. 2005. 
Serum cytokine levels evaluated in neonatal calves in relation to disease incidences up 
to 4 months after colostrum ingestion. J. Rakuno Gakuen University Nat. Sci. 29:171-
175. 
Hoebe, K., E. Janssen, and B. Beutler. 2004. The interface between innate and adaptive 
immunity. Nat. Immunol. 5:971-974.  
 41 
 
Hoffmann, A., C. Bumke, K. M. O. Hanschmann, and S. Wicker. Local thermal reaction after 
influenza vaccination: Quantification by infrared imaging and biometric consideration. 
Vaccine. 36(20):2783-2787. 
Holland, M. D. and K. G. Odde. 1992. Factors affecting calf birth weight: a review. 
Theriogenology. 38:769-798. 
Hollis, L. C., J. E. Smith, B. J. Johnson, S. Kapil, and D. A. Mosier. 2005. A comparison of 
serological responses when modified – live infectious bovine rhinotracheitis virus 
vaccine, Mannheimia haemolytica toxoid and Leptospira pomona bacterin are 
administered with needle free versus conventional needle – based injection in Holstein 
cairy calves. Bovine Pract. 39:110-114.  
Hough, R. L., F. D. McCarthy, H. D. Kent, D. E. Eversole, and M. L. Wahlberg. 1990. 
Influence of nutritional restriction during late gestation on production measures and 
passive immunity in beef cattle. J. Anim. Sci. 68; 2622-2627. 
Hudson, R. E. 2017. Evaluation of physiological stress, repiratory vaccination, and use of 
immunostimulants in beef and dairy calves. MS Thesis. West Texas A&M Univ. 
Canyon.  
Huenefeld, L. G. 1988. Veterinary Pharmaceuticals and Biologicals, ed 11. Lenexa, Kansas, 
Veterinary Medicine Publishing Group. 
Iain, J., R. L. Kerlin, K. Altman, and D. L. Watson. 1993. Adjuvants for new veterinary 
vaccines. In: R. Pandley, S. Hoglund, and G. Prasad, editors, Veterinary vaccines. 
Springer-Verlag New York Inc. New York City, NY. p. 1-18. 
Idoate, I, B. Vander Ley, L. Schultz, and m. Heller. 2015. Acute phase proteins in naturally 
occurring respiratory disease of feedlot cattle. Vet. Immun. Immunopath. 163:221-226. 
 42 
 
Ilg, T. 2017. Investigation on the molecular mode of action of the novel immunostimulatory 
Zelnate: Activation of the cGAS-STING pathway in mammalian cells. Molec. Immuno. 
90:182-189.   
Jenkins, T. G. and C. L. Ferrell. 2006. Matching beef genetics with production environment. 
BIF proceedings. 38th annual meeting. Choctaw, MS. 
Joaquin, A., L. M. Gómez, L. Mahecha, E. Mejía, J. Henao, and C. Mesa. 2015. Calf’s sex, 
parity and the hour of harvest after calving affect colostrum quality of dairy cows 
grazing under high tropical conditions. Trop. Anim. Health Pro. 47:781. doi: 
10.1007/s11250-015-0781-z. 
 Jochims, K., F. J. Kaup, and W. Drommer. 1994. An immunoelectron investigation of colostral 
IgG absorption across the intestine of new born calves. Res. Vet. Sci. 57(1):75-80. 
Johnson, L. R. 2013. Gastrointestinal Physiology. 8th ed. Elsevier Mosby. Philadelphia, PA. 
Kanyshkova, T. G., V. N. Buneva, and G. A. Nevinsky. 2001. Lactoferrin and its biological 
functions. Biochem. Moscow. 66:1-7.  
Kennedy, V. C., M. L. Bauer, K. C. Swanson, and K. A. Vonnahme. 2016. Supplementation of  
corn dried distillers grains plus soluble to gestating beef cows fed low-quality forage: I.  
Altered intake behavior, body condition, and reproduction. J. Anim. Sci.94:240–247. 
Lacy-Hulbert, S. J., M. W. Woolford, G. Nicholas, C. G. Prosser, and K. Stelwagen. 1999. 
Effect of milking frequency and pasture intake on milk yield and composition of late 
lactation cows. J. Dairy Sci. 82:1232-1239.   
Lagutchuk, M. S. G. K. Ogilvie, W. E. Wingfield. And T. B. Hackett. 1996. Lactate kinetics in 
veterinary critical care: a review. J. Vet. Emerg. Crit. Care. 6:81-95. 
 43 
 
Larson, B. L., H. L. Heary, and J. E. Devery. 1980. Immunoglobulin production and transport 
by the mammary gland. J. Dairy. Sci. 63:665-671. 
Larson, D. M., J. L. Martin, D. C. Adams, and R. N. Funston. 2009. Winter grazing systems 
and supplementation during late gestation influence performance of beef cows and steer 
progeny. J. Anim. Sci. 87:1147-1155. doi:10.2527/jas.2008-1323. 
Lascelles, A. K. and G. H. McDowell. 1974. Localized humoral immunity with particular 
reference to ruminants. Transplant Rev. 19:170-208.  
Laster, D. B., G. A. Gimp, L. V. Cundiff, and K. E. Gregory. 1973. Factors affecting dystocia 
and the effects of the dystocia on subsequent reproduction in beef cattle. J. Anim. Sci. 
9:695-705. 
Lemley, C. O., L. E. Camacho, and K. A. Vonnahme. 2015. Maternal recognition and 
physiology of pregnancy. In: R. M. Hopper, editor, Bovine reproduction. Blackwell 
Publishing, Danvers, MA. p. 247-248.  
Lemons, J. A. and R. L. Schreiner. 1983. Amino acid metabolism in the ovine fetus. Am. J. 
Physiol. 244:E459.  
Leury, B. J., A. R. Bird, K. D. Chandler, and A. W. Bell. 1990. Glucose partitioning in pregnant 
ewe: Effects of under – nutrition and exercise. Br. J. Nutr. 64:449. 
MacLennan I. C., K. M. Toellner, and A. F. Cunningham. 2003. Extracellular antibody 
responses. Immunol. Rev. 194: 8-18. 
Makimura, S. and N. Suzuki. 1982. Quantitative determination of bovine serum haptoglobin 
and its elevation in some inflammatory diseases. Jpn. J. Vet. Sci. 44:15-21. 
 44 
 
Martin, J. L., K. A. Vonnahme, D. C. Adams, J. P. Lardy, and R. N. Funston. 2007. Effects of 
dam nutrition on growth and reproductive performance in heifer calves. J. Anim. Sci. 
85:841-847. doi:10.2527/jas.2006-337. 
Mayer, B., A. Zolani, L. V. Frenyo, Z. Szentirmay, L. Hammarstrom, and I. Kackovics. 2002. 
Redistribution of sheep neonatal Fc receptor in the mammary gland around time of 
parturition in ewes and its localization in the small intestine of neonatal lambs. 
Immunology. 107(3):288-96. 
Mayer, B., M. Doleschall, B. Bender, J. Bartyik, Z. Bosze, L. V. Frenyo, and I. Kacskovics. 
2005. Expression of the neonatal Fc receptor (FcRn) in the bovine mammary gland. J. 
Dairy Res. 72:107-112. doi:10.1017/S0022029904000573. 
McDonald, T. L., M. A. Larson, D. R. Mack, and A. Weber. 2001. Elevated extrahepatic 
expression and secretion of mammary-associated serum amyloid A3 (M-SAA3) into 
colostrum. Vet. Immunol. Immunop. 83:203-211.  
McGuire, T. C., N. E. Pfeiffer, J. M. Weikel, and R. C. Bartsch. 1976. Failure of colostral 
immunoglobulin transfer in calves dying from infectious disease. J. Am. Vet. Med. 
Assoc. 169:713-718. 
McGuirk, S. M. and M. Collins. 2004. Managing the production, storage, and delivery of 
colostrum. Vet. Clin. Food Anim. 20:593-603. 
Morin, D. E., P. D. Constable, F. P. Maunsell, and G. C. McCoy. 2001. Factors associated with 
colostral specific gravity in dairy cows. J. Dairy Sci. 84:937-943.  
Mousel, M. R., T. D. Leeds, S. N. White, and L. M. Hermann-Hoesing. 2008. Technical note: 
Comparison of traditional needle vaccination with pneumatic, needle-free vaccination 
for sheep. J. Anim. Sci. 86:1468-1471.  
 45 
 
Muggli, N. E., W. D. Hohenboken, L. V. Cundiff, and K. W. Kelly. 1984. Inheritance of 
maternal immunoglobulin G1 concentration by the bovine neonate. J. Anim. Sci. 59:39-
48. 
Murata, H., N. Shimada, and M. Yoshioka. 2004. Current research on acute phase proteins in 
veterinary diagnosis: an overview. Vet. J. 168:28-40. 
Murry, G. M., R. G. O’Neill, S. J. More, M. C. McElroy, B. Earley, and J. P. Cassidy. 2016. 
Evolving in views on bovine respiratory disease: an appraisal of selected control 
measures-part 2. Vet. J. 217:78-82. 
NASS. 2011. Cattle and calf death losses. 
http://usda.mannlib.cornell.edu/usda/current/CattDeath/CattDeath-05-12-2011.pdf 
(accessed 10 June 2015)  
Nickell, J.S., D. J. Keil, T. L. Settje, K. F. Lechtenberg, V. Singu, and A. R. Woolums. 2016. 
Efficacy and safety of a novel DNA immunostimulant in cattle. Bovine Practitioner, 
50:9–20. 
NRC. 2000. Nutrient requirements of beef cattle. 7th rev. ed. Natl. Acad. Press, Washington, 
DC.  
Odde, K.G. 1988. Survival of the neonatal calf. Vet. Clin. N. Am.: Food Anim. Prac. 4:501-
508.  
Olson, D. P., L. F. Woodard, R. C. Bull, and D. O. Everson. 1981. Immunoglobulin levels in 
serum and colostral whey or protein-metabolizable energy restricted beef cows. Res. 
Vet. Sci. 30:49-52. 
 46 
 
Ontsouak, C. E., R. M. Bruckmaier, and J. W. Blum. 2003. Fractionized milk composition 
during removal of colostrum and mature milk. J. Dairy Sci. 86:2005-2011. 
doi:10.3168/jds.S0022-0302.   
Osborn, B. I., G. H. Stabenfeldt, and A. A. Ardens. 1982. Perinatal immunity in calves. J. Am. 
Vet. Med. Assoc. 164:295-298.  
Palucka, A. K., B. Laupeze., and C. Aspord. 2005. Immunotherapy via dendritic cells. Adv. 
Exp. Med. Biol. 560:105-114.  
Panciera, R. J. and A. W. Confer. 2010. Pathogenesis and pathology of bovine pneumonia. Vet. 
Clin. North Am. Food Anim Pract. 26:191-214.  
Perino, L. J., R. L. Sutherland, and N. E. Woolen. 1993. Serum gamma-glutamyltransferase 
activity and protein concentration at birth and after suckling in calves with adequate and 
inadequate passive transfer of immunoglobulin G. Am. J. Vet. Res. 54:56-59. 
Perino, L. J. 1997. A guide to colostrum management in beef cows and calves. Vet. Med. 
92:75-82.  
Perino, L. J., T. E. Wittum, and G. S. Ross. 1995. Effects of various factors on plasma protein 
and serum immunoglobulin concentrations of calves at postpartum hours 10 and 24. 
Am. J. Vet. Res. 56:1144-1148.  
Phillipson, A. T. 1970. Dukes’ Physiology of Domestic Animals. 8th ed. 424. Comstock Pub. 
Assoc. Ithaca, NY. 
Pineiro, A., J. H. Brock, and I. Esparza. 1978. Isolation and properties of bovine colostral 
trypsin inhibitor. Ann. Rech. Vet. 9(2):281-286. 
 47 
 
Pritchett, L. C., C. C. Gay, T. E. Besser, and D. D. Hancock. 1991. Management and production 
factors influencing immunoglobulin G1 concentrations in colostrum of Holstein cows. J. 
Dairy Sci. 74:2336-2341.  
Quigley, J. D., K. R. Martin, and H. H. Dowlen. 1995. Concentration of trypsin inhibitors and 
immunoglobulins in colostrum of Jersey cows. J. Dairy Sci. 78:1573-1577. 
Radunz, A. E., F. L. Fluharty, A. E. Relling, T. L. Felix, L. M. Shoup, H. N. Zerby, an S. C.  
Loerch. 2012. Prepartum dietary energy source fed to beef cows: II. Effects on progeny 
postnatal growth, glucose tolerance, and carcass composition. J. Anim. Sci. 90:4962- 
4974. 
Reber, A. J., A. Lockwood, A. R. Hippen, and D. J. Hurley. 2006. Colostrum induced 
phenotypic and trafficking changes in maternal mononuclear cells in a peripheral blood 
leukocyte model for study of leukocyte transfer to the neonatal calf. Vet. Immunol. 
Immunop. 109:139-150.  
Reibold, J. B., J. F. Coetzee, L. C. Hollis, J. S. Nickell, C. M. Riegel, J. A. Christopher and R. 
R. Ganta. 2010. Comparison of iatrogenic transmission of Anaplasma marginale in 
Holstein steers via needle and needle – free injection techniques. Am. J. Vet. Res. 
71:1178-1188.   
Rey, M. R., M. Undi, J. C. Rodriguez-Lecompte, T. Joseph, J. Morrison, A. Yitbarek, K. 
Wittenberg, R. Tremblay, G. H. Crow, and K. H. Ominski. 2013. A study of the 
effectiveness of a needle-free injection device compared with a needle and syringe used 
to vaccinate calves against bovine viral diarrhea and infectious bovine rhinotracheitis 
virus. Vet. J. 198:235-238.   
 48 
 
Rey, M. R., J. . C. Rodriguez-Lecompte, M. Undi,  T. Joseph, J. Morrison, A. Yitbarek, K. 
Wittenberg, R. Tremblay, G. Crow, and K. H. Ominski. 2015. Efficacy of needle-free 
injection on antibody production against Clostridium chauvoei in beef calves under field 
conditions. Can. Vet. J. 56(4):405-407.      
Riollet, C., P. Rainard, and B. Poutrel. 2000. Kinetics of cells and cytokines during immune-
mediated inflammation in the mammary gland of cows systemically immunized with 
Staphylococcus aureus alpha toxin. Inflamm. Res. Sep. 49:486-496.  
Robinson, J. J., I. McDonald, C. Fraser, and I. McHattie. 1977. Studies on reproduction in 
prolific ewes. I. Growth of the products of production. J. Agric. Sci. Camb. 88:539-552.  
Rogers, K. C., D. G. Miles, D. G. Renter, J. E. Sears, and J. L. Woodruff. 2017. Effects of 
delayed respiratory viral vaccine and/or inclusion of an immunostimulant on feedlot 
health, performance, and carcass merits of auction-market derived feeder heifers. Bov. 
Pract. 50(2):43-47. 
Roy, J. H. B. 1990. Management of health. In J. H. B. Roy, editor, The calf 5th ed. Butterworth-
Heinemann, London, UK. p. 1-16.  
Sandholm, M. and T. Honkanen-Buzalski. 1979. Colostral trypsin-inhibitor capacity in different 
animal species. Acta Vet. Scand. 20(4):469-476. 
Schear, D. J., F. S. Roberti, G. Schoedon, and A. Schaffner. 2002. Induction of the CD163-
dependent hemoglobin uptake by macrophages as a novel anti-inflammatory action of 
glucocorticoids. Brit. J. of Hemot. 119:239-243.  
Schlafer, D. H., P. J. Fisher, and C. J. Davies. 2000. The bovine placenta before and after birth: 
placental development and function in health and disease. Anim. Repro. Sci. 60-61:145-
160. 
 49 
 
Schroedl, W., B. Fuerll, P. reinhold, M. Krueger, and C. Schuett. 2001. A novel acute phase 
marker in cattle: lipopolysaccharide binding protein (LBP). J. Endotoxin. Res. 7:49-52.  
Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, and R. 
J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding-protein. Science. 
249:1429-1431.  
Seeber, S. J., J. L. White, and S. L. Hem. 1991. Predicting the adsorption of proteins by 
aluminum-containing adjuvants. 9:201-203.  
Siegrist, C. A. 2013. General aspects of vaccination. In S. A. Plotkin, Editor Vaccines 6th 
Edition. Elsevier Inc. Alanta, GA. 14-32. 
Smeaton, T. C. and M. W. Simpson-Morgan. 1985. Epithelial cell renewal and antibody 
transfer in the intestine of the foetal and neonatal lamb. Aust. J. Exp. Biol. Med. Sci. 
1:41-51. 
Smith, T. and R. B. Little. 1922. The significance of the colostrum to the newborn calf. F. Exp. 
Med. 36:181. 
Smith, K. L., L. A. Muir, L. C. Ferguson, and H. R. Conrad. 1971. Selective transport of IgG1 
into the mammary gland: role of estrogen and progesterone. J. dairy Sci. 54:1886-1894 
Sorge, U., D. Kelton, and R. Staufenbiel. 2009. Neonatal blood lactate concentration and calf 
morbidity. Vet. Rec. 164:533-534. doi:10.1136/vr.164.17.533. 
Stacey, T. E., A. P. Weedon, C. Haworth, R. H. T. Ward, and R. D. H. Boyd. 1978. 
Fetomaternal transfer of glucose analogues by sheep placenta. Am. J. Physiol. 234:E22 
Stalker, L. A., D. C. Adams, T. J. Klopfenstein, D. M. Feuz, and R. N. Funston. 2006. Effects of 
pre- and postpartum nutrition on reproduction in spring calving cows and calf feedlot 
performance. J. Anim. Sci. 84:2582-2589. doi:10.2527/jas.2005-640. 
 50 
 
Stanley, T. E., L. D. Corley, L. J. Bush, and W. E. Jones. 1972. The ultrastructure of neonatal 
calf intestine and absorption of heterologous protein. Anat. Rec. 172(3):559-579. 
Stark, A., O. Wellnitz, C. Dechow, R. Bruckmaier, and C. Baumrucker. 2015. Colostrogenesis 
during and induced lactation in dairy cattle. J. Anim. Phy. and Anim. Nutr. 99:356-366. 
doi:10.1111/jpn.12205.  
Stelwagen, K., E., Carpenter, B. Haigh, A. Hodgkinson, and T. T. Wheeler. 2009. Immune 
components of bovine colostrum and milk. J. Anim. Sci. 87:3-9. doi:10.2527/jas.2008.  
Stokka, G.L., A.J. Edwards, M.F. Spire, R.T. Brandt Jr. and J.E. Smith. 1994. Inflammatory 
response to clostridial vaccines in feedlot cattle. J. Am. Vet. Med. Assoc. 204:415-419. 
Stott, G. H., D. B. Marx, B. E. Menefee, and G. T. Nightengale. 1979a. Colostral 
immunoglobulin transfer in calves. I. period of absorbtion. J. Dairy Sci. 62:1632.  
Stott, G. H., D. B. Marx, B. E. Menefee, and G. T. Nightengale. 1979b. Colostral 
immunoglobulin transfer in calves. II. rate of absorbtion. J. Dairy Sci. 62:1766-1773. 
Stott, G. H., D. B. Marx, B. E. Menefee, and G. T. Nightengale. 1979b. Colostral 
immunoglobulin transfer in calves. III. amount of absorption. J. Dairy Sci. 62:1902-
1907. 
Stott, G. H. and J. Reinhard. 1978. Adrenal function and passive immunity in the dystocial calf. 
J. Dairy. Sci. 61:1457-1461. 
Su, S.B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J.M. Wang. 1990. 
A seven-transmembrane, G proteincoupled receptor, FPRL1, mediates the chemotactic 
activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:395-402. 
Sutton, M. L. 1980. Rapid onset of immunity in cattle after intramuscular injection of a 
modified live virus IBR vaccine. Vet. Med. 75:1447-1456 
 51 
 
Sweaton, T. C., and M. W. Simpson-Morgan. 1985. Epithelial cell renewal and antibody 
transfer in the intestine of the foetal and neonatal lamb. J. Exp. Biol. Med. 1: 41-51. 
Szenci, O. 1985. Role of acid-base disturbances in perinatal mortality of calves. Acta. Vet. 
Hung. 33:205-220. 
Szenci, O. 1983. Effects of type and intensity of assistance on acid-base balance of newborn 
calves. Acta. Vet. Hung. 31:73-79. 
Thompson, J. C. and J. V. Pauli. 1981. Colosrtal transfer of gamma glutamyl trasnpeptidase in 
calves. N. Z. Vet. J. 29:223-226.  
Taylor, J. D., R. W. Fulton, T. W. Lehenbauer, D. L. Step, and A. W. Confer. 2010. The 
epidemiology of bovine respiratory disease: what is the evidence for preventive 
measures? Can. Vet. J. 51(2):1351-1359.  
Titchen, D. A. 1976. Proceedings diaphragmatic and oesophageal electromyograms during 
regurgitation in sheep. J. Physiol. 258: 35-36. 
Tizard, I. R., 2013. Innate immunity: The proinflammatory and antimicrobial mediators. In: I. 
R. Tizard, editor, Veterinary immunology an introduction 9th ed. W. B. Saunders, 
Philadelphia, PA. p. 21-29.  
Todd, J.D., F. M. Volenec, and I. M. Paton. 1972. Interferon in nasal secretions and sera of 
calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: 
association of interferon in nasal secretions with early resistance to challenge with 
virulent virus. Infect. Immun. 5:699-706  
Underwood, K. R., J. F. Tong, P.L. Price, A. J. Roberts, E. E. Grings, B. W. Hess, W. J. Means, 
and M. Du. 2010. Nutrition during mid to late gestation affects growth, adipose tissue 
deposition, and tenderness in cross-bred beef steers. Meat Sci. 86: 588-593 
 52 
 
Urban-Chmiel, R. and D. L. Grooms. 2012. Prevention and control of bovine respiratory 
disease. J. Livestock Sci. 3:27-36. 
van Drunen Little – van den Hurk. 2006. Rationale and perspective on the success of 
vaccination against bovine herpesvirus – 1. Vet. Microbio. 113:275-282.  
Ventorp, M. and P. Michanek. 1992. The importance of udder and teat conformation for teat 
seeking by newborn calves. J. Dairy. Sci. 75:262-268.  
Vinuesa, C. G., S. G. Tangye, and B. Moser. 2005. Follicular B helper T cells in antibody 
responses and autoimmunity. Nat. Rev. Immunol. 5:853-865.  
Weaver, D. M., J. W. Tyler, D. C. VanMetre, D. E. Hostetler, and G. M. Barrington. 2000. 
Passive transfer of colostral immunoglobulins in calves. J. Vet. Itern. Med. 14:569-577.  
Wesse, J. S. and D. C. Jack. 2008. Needle stick injuries in veterinary medicine.  Can. Vet. J. 
49:780-784.  
Wesselink, R., K. J. Stafford, D. J. Mellor, S. Todd, and N. G. Gregory. 1999. Colostrum inake 
by dairy calves. N. Z. Vet. J. 47:31-34. 
Wheeler, T. T., A. J. Hodgkinson, C. G. Prosser, and S. R. Davis. 2007. Immune components of 
colostrum and milk: a historic perspective. J. Mammary Gland Biol. Neoplasia. 12:237-
247. doi:10.1007/s10911-007-9051-7 
Wilson, E. and C. E. Butcher. 2004. CCL28 controls immunoglobulin (Ig)A plasma cell 
accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. 
J. Exp. Med. 200:805-809. doi:10.1084/jem.20041069.  
Woodward, R. R. and R. T. Clark. A study of stillbirths in a herd of range cattle. J. Anim. Sci. 
18:85-90. 
 53 
 
Wu, G., F. W. Bazer, T. a Cudd, C. J. Meininger, and T. E. Spencer. 2004. Maternal Nutrition 
and Fetal Development. Amino Acids:2169–2172. 
Xu, L., R. Badolato, W. J. Murphy, D. L. Longo, M. Anver, S. Hale, J. J. Oppenheim, and J. M. 
Wang. 1995. A novel biologic function of serum amyloid A. Induction of T lymphocyte 
migration and adhesion. J. Immunol. 155:1184-1190.  
Yang, F., D. J. Haile, F. G. Berger, D. C. Herbert, E. Van Beveren, and A. J. Ghio. 2003. 
Haptoglobin reduces lung injury associated with exposure to blood. Am. J. of Physio. 
284:402-409. 
Zabielski R. and S. Naruse.1999. Neurohormonal regulation of the exocrine pancreas during 
postnatal development. In: S. G. Pierzynowski and R. Zabielski, editors, Biology of the 
pancreas in growing aminals. Elsevier, Amsterdam p. 151-192.  
 54 
 
CHAPTER 2. EVALUATION OF CORN SUPPLEMENTATION FOR 
OVERWINTERED BEEF COWS DURING MID – TO LATE - GESTATION ON 
INCIDENCE OF DYSTOCIA, METABOLIC AND RESPIRATORY ACIDOSIS, AND 
THE PASSIVE TRANSFER OF IMMUNITY 
Abstract 
 Objectives were to investigate effects of starch supplementation on colostrum 
production, offspring birth weight, incidence of dystocia, respiratory acidosis, and passive 
transfer of immunity. Forty – seven Angus – based multiparous beef cows carrying bull calves 
were divided randomly into two dietary treatments. Treatments were control (CON; n = 23) 
which received ad libitum access to a low – quality, forage based basal TMR only (57.54% 
TDN, 6.4% CP) and a treatment group (SUP; n = 24) receiving additional corn at 0.2% of BW 
(94.5% TDN, 7.64% CP) in addition to ad libitum access to the basal TMR. Calving ease, calf 
vigor, and mother scores, were assigned. The back right quarter of each dam’s mammary gland 
was completely emptied of colostrum and a sample was collected. Udder and teat score were 
assigned. Blood samples were collected from calves at 0 and 24 h post calving. Calves were 
weighed at 0, 6, 12, and 24 h post calving. Dams were weighed at 0 and 24 h and were assigned 
a BCS at 24 h post calving. Colostrum quantity (695.89 vs. 670.64 ± 119.5g; P = 0.88) was and 
quality (111.1 vs. 126.7 ± 7.56 mg/ml; P = 0.16) was not significantly different in CON and 
SUP fed dams respectively. Calving ease score was not significantly different in offspring from 
SUP and CON fed dams (P = 0.15). There were no differences in any blood gas parameters 
associated with metabolic and respiratory acidosis in calves born to SUP and CON fed dams. At 
24 h calves from SUP and CON fed dams achieved an appropriate level of maternal IgG to be 
considered a successful passive transfer of immunity (50.63 vs. 51.50 ± 3.45 mg/ml; P = 0.86).  
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Introduction 
 The syndesmochorial placenta of the cow forms a syncytium between the maternal 
endometrium and the fetal trophectoderm, thus separating the maternal and fetal blood supplies 
(Arthur, 1996). This separation of maternal and fetal blood supplies prevents the transmission 
immunoglobulins in utero (Weaver et al. 2000). Prevention of immunoglobulin transfer in utero 
means calves are born agammaglobulinemic, thus the calf has very little to no immunoglobulins 
in circulation (Weaver et al. 2000), and is characterized as being immuno-naïve (Barrington and 
Parish, 2001). Although immuno-naïve in utero, as the fetus develops so do the various innate 
and adaptive immune defenses (Barrington and Parish, 2001). These mechanisms can be 
characterized into those dependent on antigen recognition by antibody and or lymphocytes, 
adaptive immunity, and those that occur independent of recognition events, innate immunity 
(Barrington and Parish, 2001).  
  In addition to growth and development of the fetal immune system, fetal growth overall 
is crucial and can be affected by nutritional status of the dam. In rats, Godfrey and Barker 
(2000) demonstrated that the maternal diet can have significant long- and short-term impacts on 
offspring health. Maternal nutrition is crucial to fetal and placental development, which 
ultimately influences lifetime performance of that animal (Funston et al., 2010). Despite 
improved management techniques and extensive research on mammalian nutrition, suboptimal 
nutrition during gestation continues to be problematic for many livestock species (Wu et al., 
2004).  By d 250, uterine uptake from maternal nutrient supply is 46%, 72%, and 12% for 
glucose, amino acids, and acetate, respectively (Bell, 1995). In order to meet these requirements 
the dam may need to dramatically shift basal metabolism (Bell, 1995). 
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 Uterine uptake of glucose and acetate by the fetus also increases by 46% and 12% 
respectively (Bell, 1995). Unlike amino acid placental uptake, which is through active transport 
(Bell, 1993), glucose placental uptake occurs through facilitated diffusion (Stacey et al., 1978). 
Thus, glucose transport is dependent upon the maternal – fetal plasma glucose concentration 
gradients and responds to changes in maternal plasma glucose (Bell, 1995). Ewes deprived of 
energy are susceptible to hypoglycemia during late pregnancy (Bergman, 1973), which results 
in a reduction in uterine and fetal glucose uptake (Hay et al., 1984; Leury et al., 1990). If 
nutrient available glucose is limited in ewes, most glucose available to oxidation is made up of 
increased catabolism of amino acids, at the expenditure of protein synthesis and deposition of 
the fetus (Lemons and Schreiner, 1983).  This results in reduced fetal growth associated with 
placental synthesis and excretion of urea (Lemons and Schreiner, 1983). Supplying adequate 
levels of starch to the dam during late gestation can directly supply the placental and fetal 
tissues with glucose and indirectly directly supply the placental and fetal tissues amino acids. 
Underwood et al. (2010) saw improved final body weights, average daily gain (ADG), adjusted 
12th rib fat thickness, and hot carcass weights (HCW) in calves whose dams were provided 
improved forage quality pastures during late gestation compared to dams grazing native 
marginal forage quality. They did not see any differences in birth weight and adjusted 205 d 
weaning weights. However; Radunz et al. (2012) saw calves from corn supplemented dams had 
increased birth weight, 100 d weights, and tended to have improved weaning weights. Radunz 
et al. (2012) did not see the improved carcass characteristics that was noted by Underwood et 
al. (2010). These differences in outcomes may be due to the differences in starch availability 
from pasture forages and corn. 
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 Research on the effect of starch supplementation of dams during late gestation on 
colostrum quantity and quality has been limited with varying results. Corah et al. (1975) noted 
an increase in the number of calves dying due to scours (P = 0.04) from cows that received 
decreased energy diets; however, colostral and calf serum IgG concentrations were not 
quantified, so it is indefinite that calf mortality is due to a failure of PTI.  Ewes carrying 
singleton lambs and fed 1.5 times their metabolizable energy requirement during the last week 
of pregnancy produced 185% more colostrum than unsupplemented ewes (Banchero et al., 
2007). Most research investigating the relationships nutrition has on colostral IgG and serum 
IgG has focused on dietary restrictions. Further investigation is warranted on supplementation 
of CP, specific amino acids and/ or starches. General cow nutritional status can be visually 
measured with the use of BCS (Perino, 1997). Odde (1988) reported that first calf heifers with 
increased BCS was associated with increased serum IgG concentrations in their offspring (p = 
0.03); however, BCS in cows of all ages was not significantly (p = 0.19). Perino et al. (1995) 
did not see a relationship between BCS and serum IgG levels in the calf at 24 h. 
 Birth weight is commonly used as an initial reference point regarding the development 
of an individual animal, and it represents the culmination of the most dynamic growth and 
development process in mammalian biology (Holland and Odde, 1992). Offspring born at 
above-average BW have an increased chance of survival compared to those born at below-
average BW (Funston, et al., 2010). However, above-average BW at birth may increase varying 
incidence of dystocia (Laster et al., 1973), leading to increased birth asphyxia, metabolic and 
respiratory acidosis (Szenci, 1985), depressed immunoglobulin absorption (Odde, 1988), and 
increased predisposition to disease (Roy, 1990). Offspring with below-average BW at birth may 
lack vigor, tolerance to cold-stress (Carstens et al., 1987), resistance to infectious agents (Roy, 
 58 
 
1990), or the ability to overcome stresses of parturition during adaptation to extra uterine life 
(Woodward and Clark, 1959; Herschler et al., 1962). Increased BW at birth in livestock species 
can be advantageous or detrimental depending on production environment, thus it is critical to 
recognize the demand environment places on the animal genetics (Jenkins and Ferrell, 2006). 
 We hypothesize that starch supplementation, in the form of ground corn, to cows fed a 
low quality forage will alter colostrum production, offspring birth weight, incidence of 
dystocia, respiratory acidosis, and the passive transfer of immunity. The objectives were to 
investigate the effects of starch supplementation on colostrum production, offspring birth 
weight, incidence of dystocia, respiratory acidosis, and the passive transfer of immunity. 
Materials and Methods 
 All procedures were approved by the North Dakota State University Animal Care and 
Use Committee. As previously described by Tanner et al. (2018), 47 Angus – based 
multiparous beef cows carrying bull calves were divided randomly into two dietary treatments. 
Treatments were control (CON; n = 23) receiving ad libitum access to a low – quality, forage 
based basal TMR only (57.54% TDN, 6.4% CP) and a treatment group (SUP; n = 24) receiving 
additional corn at 0.2% of BW (94.5% TDN, 7.64% CP) in addition to ad libitum access to the 
basal TMR. Cows were stratified by BW and BCS across treatments. Cows weighed 661 ± 7.8 
kg, had a BCS of 5.2 ± 0.1 (9 – point scale), and were 7.5 ± 0.2 yr old at the start of the trial. 
The cows were housed in four adjacent pens (11 or 12 cows per pen), two for each treatment at 
the NSDU Beef Cattle Research Complex.  
 After a 3-wk acclimation period, intake was monitored and controlled by Insentec 
Roughage Feeders (Hokofarm, B. V., Markanesse Netherlands) beginning on d 110 of gestation 
for 22 wk. Cows were fitted with radio-frequency identification tags to monitor intake. The 
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Insentec Roughage Feeders are an automated system that identifies cows radio-frequency 
identification tags individually to control and monitor intake. The basal diet was provided ad 
libitum to each cow for the duration of the trial; however, the SUP was limited to 0.2% of BW 
on a 24 h period.  
 Feed was provided three times daily at 0800, 1200, and 1600. Bunks were checked and 
additional basal diet added when empty. All pens had free access to water and trace mineralized 
salt blocks (95.5 to 98.5% NaCl, 3,500 mg of Zn/kg, 2,000 mg of Fe/kg, 1,800 mg of Mn/kg, 
280 to 420 mg of Cu/kg, 100 mg of I/kg, 60 mg of Co/kg). Gestation diet 1 consisted of a basal 
diet of 45% hay, 45% wheat straw, and 10% concentrated separator byproduct on a DM basis; 
(56.45% TDN; 6.42% CP) and was fed from d 110 of gestation until d 153. Due to the loss of a 
cow from an impacted abomasum, diets were adjusted on d 154 to 60% hay, 30% wheat straw, 
and 10% concentrated separator byproducts (Gestation diet 2; 58.63% TDN, 7.11% CP DM 
basis) until 2 weeks prior to calving (d 265 of pregnancy). Corn was supplemented to the SUP 
group at 0.2% (87.6% TDN, 7.64% CP on DM basis) of BW from d 110 until d 265. On d 265 
of gestation, approximately 2 wk before expected parturition, all cows were fed the same diets 
(45% straw, 25% DDGS, 30% corn silage; 62.4% TDN and 11.6% CP on a DM basis) for ad 
libitum intake for a period of 5 wk; corn supplementation ceased. 
 All feed samples were analyzed for ash, CP, NDF, ADF, EE, Ca, and P. Forage samples 
were dried in a 55° C oven for 48 h and ground to pass through a 1-mm screen. Forage and 
DDGS samples were analyzed for DM, ash, N (Kjehldahl method), Ca, P, and EE by standard 
procedures (AOAC, 1990). Crude protein was calculated by multiplying N concentration x 
6.25. NDF (using heat stable amylase and sodium sulfite and expressed inclusive of residual 
ash) and ADF (expressed inclusive of residual ash) concentration were analyzed sequentially by 
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methods of Robertson and Van Soest (1981) using a fiber analyzer (Ankom Technology Corp., 
Fairport, NY).   
 During calving, cows were allowed to remain in their pens with the group until signs of 
labor were observed. If it was possible to move the cow inside the barn without causing undo 
stress, she was brought inside and put in an individual pen for calving, otherwise she was 
allowed to calve outside with the group and the cow-calf pair was immediately brought inside. 
Cows had access to hay and water ad libitum in the calving barn. A calving ease score was 
assigned post labor (1 = no assistance; 5 = caesarian section). Calves were immediately 
removed from the pen, where a blood sample was taken via jugular venipuncture and a wet 
weight (kg) was recorded. Excess amniotic fluid was removed and dry weight (kg) was 
recorded. During this time the cow was removed and placed into the Silencer Hydraulic 
Squeeze Chute (Moly Manufacturing Inc., Lorraine KS.) For each cow, weight was determined, 
and the right rear quarter was milked completely to collect a colostrum sample. Total colostral 
weight was recorded (g). A subsample was placed in cryo-vials and frozen at -20° C until later 
analysis. An udder score (1 = very pendulous with a broken floor; 9 = very tight) and teat size 
scores (1 = very large, balloon–shaped; 9 = very small) was assigned to each dam. The cow calf 
pair was then placed back into the pen. Calves were allowed to nurse from dam. A calf vigor 
score (1 = normal; 5 = stillborn) was assigned to each calf and mothering score (1 = the dam 
was up within ten minutes after delivery, is actively licking the calf to stimulate standing and is 
vocalizing to the calf encouraging it to nurse; 4 = cow shows aggression towards calf, will not 
let calf nurse, and does not vocalize) was assigned to each dam. Each cow calf pair was 
monitored for signs of general health. Calves were removed from the pen and weighed at 6, 12, 
and 24 h post calving. At 24 h post calving calves were once more removed from the pen and a 
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second blood sample was collected via jugular venipuncture. Cows were weighed and assigned 
a BCS (1 = emaciated and 9 = obese; Wagner et al., 1988) by three technicians 24 h post 
calving.  
 All blood samples were collected via 7 ml red top CORVAC serum separation tubes 
(VWR, Radnor, P. A.). Immediately following collection, 100 µL of whole blood was pipetted 
from the CORVAC serum separation tubes, approximately 80 - 100 µL was pipetted into a 
CG4+ i-STAT cartridge (measuring blood pH, pCO2, pO2, Base Excess, HCO3, TCO2, sO2, and 
Lactate). Cartridges were placed into the Vetscan i-STAT 1 handheld analyzer (Abaxis North 
America, Union City, California, 94587.). Remaining blood samples were placed in a 
refrigerator at 1° C for 30 min and centrifuged for 20 min at 1,380 x g to separate serum, which 
was then pipetted into cryo-vials and frozen at -20° C until later analysis. Serum and colostrum 
samples in cryo-vials were taken out of freezer and placed in sample tube holders at room 
temperature (21° C) until completely thawed. Subsamples were pipetted into new cryo-vials 
and placed in Styrofoam coolers with icepacks and shipped overnight to The Saskatoon 
Colostrum Co. LTD where radial immunodiffussion (U.S. Veterinary Biological Permit No. 
448A) was used to measure total IgG concentration in the colostrum and serum samples. The 
Saskatoon Colostrum Co. LTD also analyzed a subsample of colostrum to determine a Brix 
percentage using a Palm Abbe digital refractometer #PA202X (Misco, Solon, Ohio, 44139)  
 Data were analyzed using the mixed procedure of SAS (SAS Institute Inc., Cary N.C.). 
The model included fixed effects of maternal diet (SUP vs. CON), time, pen, and there 
interactions. Sire was included in the model as a random effect. Variables were analyzed at 0 
and 24 h. 0 h was used as a covariate for 24 h parameter. Calf body weight included fixed 
 62 
 
effects of maternal diet (SUP vs. CON), time and their interactions, pen, calving ease score, and 
gestation length. Significance was determined at an alpha P ≤ 0.05.    
Results  
 As previously reported by Tanner et al. (2018), there was a day by treatment interaction 
on maternal BCS (P = 0.03) where SUP dams gained BCS at a faster rate than CON dams 
which maintained BCS over pregnancy. Tanner et al. (2018) also noted a day by treatment 
interaction on maternal BW (P < 0.01), both SUP and CON dams increased BW over time. At 
partition, on d 278, dam BW was not different between SUP and CON dams (P = 0.30; Table 
2.1.). At 24 h post – partum dam BW (P = 0.18) and BCS (P = 0.71) was not significantly 
different between SUP and CON dams. Mothering (P = 0.13), udder (P = 0.08), and teat (P = 
0.83) scores did not between SUP and CON dams.   
   
Table 2.1.  Influence of treatment on dam parturition parameters. 
  Treatment    
Item   Control Supplement   SEMa P Value 
0 Hour        
          Dam weight, kgb  697 718  14.0 0.30 
          Mothering Score 1.12 0.97  0.07 0.13 
          Udder Score  6.18 5.27  0.36 0.08 
          Teat Score  6.16 6.27  0.37 0.83 
24 Hour       
          Dam weight, kgb  694 701  3.9 0.18 
          Dam BCSb   5.36 5.41   0.14 0.71 
aStandard error of the mean (n = supplement 24; control 23).    
bTanner et al., 2018       
  
 Maternal diet tended to affect calf BW (P = 0.08; Figure 2.1.). Six h post – partum 
offspring form SUP dams had an increased BW compared to offspring from CON dams (P = 
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0.01). However, by 12 and 24 post – partum that there was no significant differences calf BW 
(P = 0.08). As previously reported by Tanner et al. (2018), at an average age of 3 wk post – 
partum calves from SUP dams were heavier (P = 0.05) than calves from CON dams. However, 
by weaning there was no significant difference (P = 0.64) in calves born either SUP or CON 
dams.       
     
 
 
 At 0 h, pH, partial pressure of carbon dioxide (pCO2), partial pressure of oxygen (pO2), 
bicarbonate (HCO3), total carbon dioxide (TCO2), oxygen saturation (SO2), lactate, and base 
excess from whole blood were not different in offspring born to SUP or CON fed dams (Table 
2.2.). Also, at 24 h, pH, pCO2, pO2, HCO3, TCO2, SO2, lactate, and base excess from whole 
blood were not different in offspring born to SUP or CON fed dams.  
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Figure 2.1. Calf body weight (kg) by maternal dietary treatment across time 
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Table 2.2. Influence of treatment on blood parameters in offspring.  
  Treatment    
Item   Control Supplement   SEMa P Value 
0 Hour       
           pH  7.27 7.27  0.02 0.99 
           pCO2, mmHg  63.0 65.9  2.52 0.29 
           pO2, mmHg  24.0 21.7  1.15 0.17 
           HCO3 mmol/L  29.1 30.5  0.70 0.16 
           TCO2 mmol/L  31.1 32.4  0.75 0.24 
           SO2 %  34.2 28.6  2.62 0.14 
           Lactate, mmol/L  4.20 4.60  0.51 0.60 
           Base Excess, mmol/L  2.54 3.66  0.84 0.36 
24 Hour       
           pH  7.01 7.51  0.20 0.09 
           pCO2, mmHg  45.28 44.66  1.54 0.78 
           pO2, mmHg  25.75 28.15  2.14 0.33 
           HCO3 mmol/L  25.53 27.10  0.92 0.13 
           TCO2 mmol/L  26.82 28.62  0.67 0.08 
           SO2 %  44.18 5122  5.59 0.27 
           Lactate, mmol/L  4.12 4.21  0.91 0.94 
           Base Excess, mmol/L  0.08 2.11  1.03 0.07 
aStandard error of the mean (n = supplement 24; control 23).    
 
 Total colostral weight was not different between SUP and CON fed dams (P = 0.88; 
Table 2.3.). Also, colostral IgG was not different between SUP and CON fed dams (P = 0.16; 
Table 2.3.). However, Brix% tended to be greater in colostrum of SUP dams (126.7 vs. 111.1 ± 
7.56%, P = 0.056; Table 2.3.) compared to CON fed dams. At 24 h, there was no differences in 
serum IgG (P = 0.86; Table 2.3.) and serum protein (P = 0.55; Table 2.3.) between offspring 
born from SUP and CON dams.     
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Table 2.3. Influence of treatment on maternal colostrum and serum protein and IgG in 
offspring.  
  Treatment    
Item   Control Supplement   SEMa P Value 
0 Hour        
           Colostrum weight, gb  696 671  112 0.88 
           Colostrum Brix%  21.8 25.1  1.17 0.056 
           Colostral IgG, mg/mL  111 127  7.6 0.16 
24 Hour       
           Serum IgG, mg/mL  50.6 51.5  3.45 0.86 
           Serum protein, g/dL  6.95 7.15  0.23 0.55 
aStandard error of the mean (n = supplement 24; control 23).    
bTanner et al., 2018    
 
 
 Calving ease score was not different for offspring from SUP and CON fed dams (P = 
0.15; Table 2.4.). Calf vigor score was not different for offspring from SUP and CON fed dams 
(P = 0.77; Table 2.4.). 
 
Table 2.4. Influence of treatment on incidence of dystocia and vitality of offspring.  
  Treatment    
Item   Control Supplement   SEMa P - Value 
           Calving Ease Score  1.00 1.10  0.05 0.15 
           Calf Vigor Score  1.09 1.06  0.08 0.77 
aStandard error of the mean (n = supplement 24; control 23).    
 
Discussion 
  We reject our hypothesis that starch supplementation, in the form of ground corn, 
offered to cows fed a low quality forage will alter colostrum production, offspring birth weight, 
incidence of dystocia, respiratory acidosis, and the passive transfer of immunity. 
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 As previously mentioned by Tanner et al. (2018), TDN and NEm intake was increased in 
SUP cows compared to CON dams; however, there was a forage intake suppression in SUP 
cows. The inverse relationship of corn supplementation on forage intake has been demonstrated 
in beef cattle fed forage – based diets (Lusby and Wagnar, 1986). This inverse relationship 
between corn supplementation on forage intake is known as substitution (Caton and 
Dhuyvetter, 1997). Though there was some evidence of improved weight gain and BCS earlier 
in the trial, maternal weight and BCS were not different at parturition or 24 h post – partum. 
Odde (1988) reported that first calf heifers with increased BCS was associated with increased 
serum IgG concentrations in their offspring; however, BCS in cows of all ages was not. Perino 
et al. (1995) did not see a relationship between BCS and serum IgG levels in the calf at 24 h.  
 There is little evidence of a direct link between gestational cow nutrition and passive 
immune transfer (PIT) in calves (Perino, 1997). There were no differences in colostrum 
quantity (695.89 vs. 670.64 ± 119.5g; P = 0.88) between cows on CON or SUP diets. Colostral 
IgG (111.1 vs. 126.7 ± 7.56mg/ml; P = 0.16) was not different in CON and SUP fed dams 
respectively. High quality colostrum has an IgG concentration greater than 50 mg/mL 
(McGuirk and Collins, 2004). The average concentration of IgG in beef breeds (predominantly 
Hereford and Angus) is 57.65 mg/mL in dams ranging in age from 2-9 plus years (Odde, 1988). 
Both SUP and CON dams in this trial had twice the concentration of IgG in their colostrum 
noted by McGuirk and Collins (2004). Interestingly, colostrum Brix % tended to be greater in 
SUP dams compared to CON dams (25.10 vs. 21.77 ±1.17%; P = 0.056). Brix refractometers 
measures total dissolved solids in colostrum, which is different than RID which only measures 
bioactive IgG (Bartier et al., 2015).  Total solids in milk and colostrum is made up of fat, 
proteins, lactose, and minerals (IDFA, 2018). In addition to and more important than the 
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nutritional value of total solids, colostrum contains a complex of white blood cells and proteins 
that actively protect the neonate from pathogens and other extra-uterine challenges (Bendixen et 
al., 2011). In addition to IgG, colostrum contains viable cells such as neutrophils and 
macrophages, which secrete numerous immune-related components, as well as 
oligosaccharides, gangliosides, acute phase proteins, immunomodulatory factors, ribonucleases, 
and a range of peptide and proteins with antimicrobial activity (Stelwagen et al., 2009). All of 
these solids are quantified in the Brix % (Bartier et al., 2015). Though bioactive IgG was not 
significant between treatment groups, total solids tended to be increased in SUP dams. It should 
be noted that no other immune cells or proteins were quantified in colostrum during this trial, so 
no determinations can be made if increases in total solids of colostrum are nutritional or 
immune components.     
 Birth weight is commonly used as an initial reference point when regarding the 
development of an individual animal, and it represents the culmination of the most dynamic 
growth and development process in mammalian biology (Holland and Odde, 1992). Offspring 
born at above-average BW have an increased chance of survival compared to those born at 
below-average BW (Funston, et al., 2010). However, above-average BW at birth may increase 
varying incidence of dystocia (Laster et al., 1973), leading to increased birth asphyxia, 
metabolic and respiratory acidosis (Szenci, 1985), depressed immunoglobulin absorption 
(Odde, 1988), and increased predisposition to disease (Roy, 1990). In the current trial, calf BW 
at birth tended to be different (P = 0.08). Six h post – partum offspring form SUP dams had an 
increased BW compared to offspring from CON dams (P = 0.01; Figure 2.1.). However, by 12 
and 24 post – partum that there was no significant differences calf BW (P = 0.08).   
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 Incidence of dystocia, as measured by calving ease score, was not different across 
maternal dietary treatment groups. Only three dams needed birthing assistance, which was 
minimally invasive and was measured as a two for calving ease score. Calf activity post – 
partum, as measured by calf vigor score, was not significantly different across treatment groups. 
Again, similar to calving ease score, there was very little variation in this variable, which could 
strengthen the fact that dystocia was a factor in this trial. All blood gas parameters used to 
quantify metabolic and respiratory acidosis were not significant different across maternal 
dietary treatment groups. Ranges for venous blood pH, pCO2, pO2, HCO3, and base excess were 
all within normal ranges at 0 h for new born calves (Bluel et al., 2007). Ranges for venous 
blood pCO2, pO2, HCO3, and base excess were all within normal ranges at 24 h for neonatal 
calves (Bluel et al., 2007). Worth noting is that pH in venous blood at 24 h for calves born to 
CON dams was 7.01, which is considered acidotic (Bluel et al., 2007). This could be related to 
the 6 h BW of calves, were calves born to SUP dams had increased BW. Calves born to CON 
dams did not gain 6 h post calving at the rate of calves from SUP dams. This could be due to 
the CON calves acidic blood pH. Calves with inadequate serum IgG concentrations (<8 mg/ml) 
at 24 h are from 3.2 to 9.5 times more likely to become sick and 5.4 times more likely to die 
before weaning compared to calves with adequate concentrations of serum IgG (>16 mg/ml) 
(Perino et al., 1993). When calves have inadequate serum IgG concentrations (<8 mg/ml) a 
failure of passive transfer (FPT) of immunity has occurred (Perino et al., 1993). Calves born 
from CON and SUP dams had 24 h serum IgG levels three times the 16 mg/ml threshold for an 
adequate immune transfer (Perino et al., 1993). Calves born from CON and SUP dams had 
serum protein levels at 24 h that exceed 5.2 g/dl, which is also attributed to a FPT at 24 h (Tyler 
et al., 1996).      
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Conclusion  
 Though starch supplemented to cows fed a low quality forage did not alter colostrum 
production, offspring birth weight, incidence of dystocia, respiratory acidosis, and the passive 
transfer of immunity, it adds to a lacking body of literature. The majority of more recent 
colostrum research has focused around the dairy calf. There have been very few research trials 
examining how nutrient supplementation of the dam and the effects on neonatal calf health. The 
vast majority of research has examined maternal nutrient restriction and effects on calf health. 
Much of the data is from decades earlier and it is important to continue updating the body of 
literature using cattle genetics in current production beef herds. With more universities and 
research institutes acquiring systems such as GrowSafe and Insentec Roughage Feeders, very 
accurate and precise rations can be fed to individual animals. This allows researchers to develop 
precision research trials looking at factors that affect colostrum production and the passive 
transfer of immunity in neonatal beef calves.  
Literature Cited  
Arthur, G. H. 1996. The development of the conceptus. In: Arthur, G. H., D. E. Nokes, H. 
Pearson, and T. J. Parkinson, editors, Pregnancy and parturition in veterinary 
reproduction and obstetrics, 7th ed. WB Saunders, Philadelphia, PA. p. 51-109.  
Banchero, G. E., G. Quintans, A. Vazquez, F. Gigena, A. La Manna, D. R. Lindsay, and J. T. B. 
Milton. 2007. Effects of supplementation of ewes with barley or maize during the last 
week of pregnancy on colostrum production. Animal 1:625-630.  
Barrington, G.M. and S. M. Parish. 2001. Bovine neonatal immunology. Vet. Clin. North Am. 
Food Anim. Pract. 3:463-476. 
 70 
 
Bartier, A. L., M. C. Windeyer, and L. Doepel. 2015. Evaluation of on-farm tools for colostrum 
quality measurements. J. Dairy. Sc. 98 (3)1878-1884. 
Bell, A. W. 1995. Regulation of organic nutrient metabolism during transition from late 
pregnancy to early lactation. J. Anim. Sci. 73:2804-2819. 
Bendixen, E., M. Danielson, K. Hollung, E. Gianazza, and I. Miller. 2011. Farm animal 
proteomics: a review. J. Proteomics. 74:282-293. doi:10.1016/j.jprot.2010.11.005.  
Bergman, E. N. 1973. Glucose metabolism in ruminants as related to hypoglycemia and ketosis. 
Cornell Vet. 63:341. 
Bleul, U., B. Lejeune, S. Schwantag, and W. Kahn. 2007. Blood gas and acid base analysis of 
aterial blood in 57 newborn calves. Vet. Record. 161:688-691 
Carstens, G. E., D. E. Johnson, M. D. Holland, and K. G. Odde. 1987. Effects of prepartum 
protein nutrition and birth weight on basal metabolism in bovine neonates. J. Anim. Sci. 
65:745-751. 
Caton, J. S. and D. V. Dhuyvetter. 1997. Influence of energy supplementation on grazing 
ruminants: requirements and responses. J. Anim. Sci. 75:533-542. 
Corah L. R., T. G. Dunn, and C. C. Kaltenbach. 1975. Influence of prepartum nutrition on the 
reproductive performance of beef females and the performance of their progeny. J. 
Anim. Sci. 41(3):819-824.  
Funston R. N., D. M. Larson, and K. A. Vonnahme. 2010. Effects of maternal nutrition on 
conceptus growth and offspring performance: implications for beef cattle production. J. 
Anim. Sci. 88:E205-E215. doi:10.2527/jas.2009-2351. 
Godfrey, K. M. and D. J. Barker. 2000. Fetal nutrition and adult disease. Am. J. Clin. Nutr. 
71:1344S-1352S. 
 71 
 
Hay, W. W., Jr., W. Sparks, R. B. Wilkening, F. C. Battaglia, and G. Meschia. 1984. Fetal 
glucose uptake and utilization as functions of maternal; glucose concentration. Am. J. 
Physiol. 246: E237. 
Herschler, M. S., N. S. Fechheimer, and L. O. Gilmore. 1962. Congenital abnormalities in 
cattle: their association with heredity and environmental factors. J. Dairy Sci. 45:1493-
1499. 
Holland, M. D. and K. G. Odde. 1992. Factors affecting calf birth weight: a review. 
Theriogenology. 38:769-798. 
Jenkins, T. G. and C. L. Ferrell. 2006. Matching beef genetics with production environment. 
BIF proceedings. 38th annual meeting. Choctaw, MS. 
Laster, D. B., G. A. Gimp, L. V. Cundiff, and K. E. Gregory. 1973. Factors affecting dystocia 
and the effects of the dystocia on subsequent reproduction in beef cattle. J. Anim. Sci. 
9:695-705  
Lemons, J. A. and R. L. Schreiner. 1983. Amino acid metabolism in the ovine fetus. Am. J. 
Physiol. 244:E459.  
Leury, B. J., A. R. Bird, K. D. Chandler, and A. W. Bell. 1990. Glucose partitioning in pregnant 
ewe: Effects of under – nutrition and exercise. Br. J. Nutr. 64:449. 
Lusby, K.S. and D. G. Wagner. 1968. Effects of supplements on feed intake. In: F.N. Owens 
(Ed.) Feed Intake by Beef Cattle. p 173. Okla. Agric. Exp. Sta. MP 121. Stillwater. 
McGuirk, S. M. and M. Collins. 2004. Managing the production, storage, and delivery of 
colostrum. Vet. Clin. Food Anim. 20:593-603. 
Odde, K.G. 1988. Survival of the neonatal calf. Vet. Clin. N. Am.: Food Anim. Prac. 4:501-
508.  
 72 
 
Perino, L. J. 1997. A guide to colostrum management in beef cows and calves. Vet. Med. 
92:75-82.  
Perino, L. J., T. E. Wittum, and G. S. Ross. 1995. Effects of various factors on plasma protein 
and serum immunoglobulin concentrations of calves at postpartum hours 10 and 24. 
Am. J. Vet. Res. 56:1144-1148. 
Radunz, A. E., F. L. Fluharty, A. E. Relling, T. L. Felix, L. M. Shoup, H. N. Zerby, an S. C.  
Loerch. 2012. Prepartum dietary energy source fed to beef cows: II. Effects on progeny 
postnatal growth, glucose tolerance, and carcass composition. J. Anim. Sci. 90:4962- 
4974. 
Robinson, J. J., I. McDonald, C. Fraser, and I. McHattie. 1977. Studies on reproduction in 
prolific ewes. I. Growth of the products of production. J. Agric. Sci. Camb. 88:539-552.  
Roy, J. H. B. 1990. Management of health. In J. H. B. Roy, editor, The calf 5th ed. Butterworth-
Heinemann, London, UK. p. 1-16. 
Stacey, T. E., A. P. Weedon, C. Haworth, R. H. T. Ward, and R. D. H. Boyd. 1978. 
Fetomaternal transfer of glucose analogues by sheep placenta. Am. J. Physiol. 234:E22 
Stelwagen, K., E., Carpenter, B. Haigh, A. Hodgkinson, and T. T. Wheeler. 2009. Immune 
components of bovine colostrum and milk. J. Anim. Sci. 87:3-9. doi:10.2527/jas.2008.  
Szenci, O. 1983. Effects of type and intensity of assistance on acid-base balance of newborn 
calves. Acta. Vet. Hung. 31:73-79. 
Tanner, A. R., V. C. Kennedy, M. L. Bauer, K. C. Swanson, J. D. Kirsch, J. J. Gaspers, N. 
Negrin-Pereira, A. B. P. Fontoura, G. A. Perry, G. L. Stokka, A. Rodas-Gonzalez, A. 
Ward, C. R. Dahlen, B. Neville, L. P. Reynolds, K. H. Ominski, and K. A. Vonnahme. 
2018. Corn supplementation as a winter-feeding strategy alters maternal feeding 
 73 
 
behavior and endocrine profiles in mid- to late-gestating beef cows. J. Anim. Sci. 2:106-
111.  
Tyler, J. W., D. D. Hancock, S. M. Parish, D. E. Rea, T. E. Besser, S. G. Sanders, and L. K. 
Wilson. 1996. Evaluation of 3 assays for failure of passive transfer in calves. J. Vet. 
Intern. Med. 10:304-307 
Underwood, K. R., J. F. Tong, P.L. Price, A. J. Roberts, E. E. Grings, B. W. Hess, W. J. Means, 
and M. Du. 2010. Nutrition during mid to late gestation affects growth, adipose tissue 
deposition, and tenderness in cross-bred beef steers. Meat Sci. 86: 588-593 
Weaver, D. M., J. W. Tyler, D. C. VanMetre, D. E. Hostetler, and G. M. Barrington. 2000. 
Passive transfer of colostral immunoglobulins in calves. J. Vet. Itern. Med. 14:569-577.  
Woodward, R. R. and R. T. Clark. A study of stillbirths in a herd of range cattle. J. Anim. Sci. 
18:85-90. 
Wu, G., F. W. Bazer, T. a Cudd, C. J. Meininger, and T. E. Spencer. 2004. Maternal Nutrition 
and Fetal Development. Amino Acids:2169–2172. 
 
  
 74 
 
CHAPTER 3. IMPACT OF NEEDLE – FREE INJECTION DEVICE ON 
SEROLOGICAL IMMUNE RESPONSE AND INJECTION SITE REACTION TO A 
MODIFIED LIVE BVDV TYPE ONE AND TWO VACCINE WITH A MANNHEIMIA 
HAEMOLYTICA TOXOID 
Abstract 
 The objective of this study was to evaluate the impact of a needle – free injection device 
(NF) on serological innate and adaptive immune responses to a MLV BVDV type one and two 
vaccine with a Mannheimia haemolytica toxoid. At 60 d of age, steers (129.1±6.98kg, n = 43) 
born from dams that were supplemented with corn during mid – to late – gestation and steers 
born from cows on the control diet were randomly assigned to either vaccination using needle 
and syringe (NS) (Non – supplemented = 10 and supplemented = 11; n = 21) or using a NF 
(Non – supplemented = 11 and supplemented = 11; n = 22). On d 0 of the trial, both treatment 
groups received a 2 cc dose of MLV BVDV type one and two vaccine with a Mannheimia 
haemolytica toxoid. Haptoglobin (Hp) and BVDV type 2 antibody titers were used as a proxy to 
measure serological innate and adaptive vaccine immune responses. Maternal diet did not 
significantly affect Hp (P = 0.78) or BVDV type 2 antibody titers (P = 0.23). Inflammatory 
response was observed for both NS and NF treatment groups (P < 0.001). After injection, 
BVDV type 2 antibody titers continually declined from d 0, 7, 28, and 115 across both NS and 
NF treatment groups (P < 0.001). After secondary booster vaccination on d 115, BVDV type 2 
antibody titers significantly increased by d 143 (P < 0.001).   
Introduction 
 Observations through the past two centuries have shown the benefits of immunization 
and that vaccinations are one of the most cost-effective methods to preventing economic losses 
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and reduce the risk of disease in livestock (Babiuk, 2002). In livestock, the major causes of 
death preceding slaughter are due to infectious diseases (Babiuk, 2002). Bovine respiratory 
disease complex (BRDC) persists as the single most costly disease syndrome associated with 
commercial beef production in the United States, accounting for losses in 2010 of 1,055,000 
animals valued at $643 million (NASS, 2011). Increased morbidity and mortality, decreased 
weight gains, decreased feed utilization, and decreased carcass quality account for the economic 
losses associated with BRDC (Edwards, 2010). The morbidity risk of BRDC in feedlot cattle 
occurs in the first 45 d after arrival into the feedlot with the highest risk occuring in wk 1 to 3, 
after that morbidity declines (Buhman et al., 2000; Edwards, 1996). 
 To help combat this costly inefficiency, cattle producers have implemented vaccination 
protocols for their beef herds. The viral vaccine components of BRDC consist of bovine 
herpesvirus type 1, also known as infectious bovine rhinotracheitis (IBR), bovine viral diarrhea 
(BVD), parainfluenza virus type 3 (PI-3), and bovine respiratory syncytial virus (BRSV) 
(Urban-Chmiel and Grooms, 2012). The bacterial vaccine components of BRDC consists of 
Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni (Urban-Chmiel and 
Grooms, 2012). Killed and modified live vaccines (MLV) are available in different 
combinations of viral pathogens (Urban-Chmiel and Grooms, 2012). The appropriate use of 
these vaccines can reduce the risk of BRDC (Urban-Chmiel and Grooms, 2012). Disease 
control or elimination requires the stimulation of the immune system in a sufficient proportion 
of the population or herd (Siegrist, 2013). Immunization is achieved by inducing protection, as 
a result of stimulating the adaptive immune system (Siegrist, 2013). This immunity is achieved 
by the maintenance of antigen-specific immune effectors and/or by the induction of immune 
memory cells that can reactivate if re-exposure to the antigen occurs (Siegrist, 2013). 
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 In order to elicit a vaccine response, a vaccine must provide enough danger signals from 
the antigen, typically paired with an adjuvant, to trigger the inflammatory reaction that is 
mediated by cells of the innate immune system (Hoebe et al., 2004). Upon injection of vaccine 
antigens, an acute phase inflammation develops within minutes (Tizard, 2013). Upon injection 
of an antigen, broken cells release molecules known as damage-associated molecular patterns 
(DAMPs) that trigger the release of cytokines, chemokines, and enzymes from sentinel cells 
(Tizard, 2013). The antigens also provide pathogen-associated molecular patterns (PAMPs) that 
trigger sentinel cell response (Tizard, 2013). This causes the sentinel cells to synthesize and 
secrete a mixture of molecules that trigger inflammation and initiates the first steps of the 
adaptive immune system (Tizard, 2013). The three major cytokines secreted by sentinel cells 
include tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6) (Tizard, 
2013). 
 The release of TNF-α, IL-1, and IL-6 increases protein synthesis, specifically acute 
phase proteins (APP) (Tizard, 2013). Acute phase proteins are a group of blood proteins that 
change in concentration when an animal is subjected to external or internal challenges, such as 
infection, inflammation, and stress (Murata et al., 2004). One of the most prominent APP found 
in beef cattle is haptoglobin (Hp) (Alsemgeest et al., 1994). Hp concentrations in healthy cattle 
are often undetected, but during an acute phase response bovine haptoglobin can increase 50-
100 times (Conner et al., 1988). However, Hp concentrations observed post vaccination with 
killed clostridial 7 – way bacterin toxoids or BRDC 5 – way MLV viral vaccines with a 
Mannheimia haemolytica toxoid have been closer to 4 – 7 fold increases post injection (Stokka 
et al., 1994; Gaspers et al., 2018). Hp concentrations will increase with both bacterial and viral 
infections (Schroedl et al., 2001; Ganheim et al., 2003; Heegaard et al., 2000; Idoate et al., 
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2015), and Hp can be used as a tool to measure respiratory disease in feedlot conditions (Idoate 
et al., 2015). 
 Inflammation and actions of the innate immune system may be sufficient to protect the 
body, but it cannot be guaranteed to provide complete resistance to infection, or assist the body 
to learn from the experience (Tizard, 2013). This limitation of the innate immune response is 
the advantage of the adaptive immune response (Tizard, 2013). Dendritic cells are the link 
between the innate and adaptive immune system. When exposed to an antigen, dendritic cells 
undergo a maturation process, modulating specific surface receptors and migrate towards the 
lymphatic system, in secondary lymph nodes (Siegrist, 2013). Phagocytosed antigen is loaded 
onto the MHC class II molecules and presented to T cells (Tizard, 2013). The central role of 
dendritic cells, in response to a vaccine, is to provide antigen-specific and costimulatory signals 
to activate naïve T cells (Palucka et al., 2005). 
 The MHC-peptide complex is displayed on their surface and binds to a subset of CD4+ 
T cells, follicular helper T cells (Siegrist, 2013). These follicular helper T cells have different 
sets of chemokine receptors, transcription factors, surface markers, and interleukins that are 
uniquely equipped to provide the most efficient B cell help through a series of coststimulatory 
molecules (Vinuesa et al., 2005). The interactions between antigen-specific germinal center B 
cells, antigen bearing follicular dendritic cells, and follicular helper T cells results in the 
production of B cells with the highest level of antigen-specific affinity (Siegrist, 2013). This 
combination provides signals necessary for the differentiation of germinal center B cells either 
towards plasma secreting specific antibodies or towards memory B cells (Siegrist, 2013). 
Antigen specific antibodies have been formally demonstrated as conferring vaccine-induced 
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protection against many diseases, and the production of memory B cells allows for the long 
term disease protection (Casadevall, 2004). 
 The majority of cattle vaccines administered to cattle are parenteral, either intramuscular 
or subcutaneous, using a needle and syringe (Babiuk et al., 2017). There are potential 
drawbacks to this vaccine delivery method. Improper handling of needles can result in 
accidental injury to the individual operator as well as the animal receiving vaccine (Weese and 
Jack, 2008). There is also risk that needle fragments may break off during injection and remain 
in the muscle of the animal to slaughter (van Drunen Little-van den Hurk, 2006). Additionally, 
blood – born infectious agents such as bovine leucosis and anaplasmosis as well as organisms 
on the skin can be transmitted between animals if one needle is used to inject multiple animals 
(Hollis et al., 2005; Reinbold et al., 2010). These concerns have led to the design of alternative 
vaccination techniques, including the use of needle – free injection devices (NFs) (Rey et al., 
2013).  
 NF’s use compressed gas, typically CO2 or N2, at pressures ranging from 310.3 – 448.2 
kPa (Rey et al., 2015). Upon triggering the device, the desired volume of vaccine is forced 
through a small orifice which forms a high pressure stream that can penetrate the skin and 
deposit the vaccine into the desired tissue (Mousel et al., 2008). This vaccination technique 
removes the issues observed with needles, helps reduce disease transfer, and reduces 
vaccination time (Chase et al., 2008; Reinbold et al., 2010; Mousel et al., 2008). This 
vaccination technique has been shown to elicit serological immune responses in cattle to 
Mannheimia haemolytica, IBRV, and BVDV (Hollis et al., 2005; Rey et al., 2013). The 
objective of this study was to evaluate the influence of NF’s on serological innate and adaptive 
immune responses to a MLV BVDV type one and two vaccine with a Mannheimia haemolytica 
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toxoid. We hypothesized that the both NF as well as needle and syringe (NS) will induce a 
significant innate and adaptive immune response which will result in long term immunological 
memory.  
Materials and Methods 
 All procedures were approved by the North Dakota State University (NDSU) and 
University of Manitoba (UM) Animal Care and Use Committees. Forty – three Angus – based 
Cow – calf pairs, from the colostrum trial described in chapter 2, were moved as a single group 
from NDSU’s Beef Cattle Research Complex to pasture in mid – May at the Central Grassland 
Research and Extension Center. At 60 d of age (mid – June) steers (129.1±6.98kg, n = 43) born 
from dams that were supplemented corn during mid – to late – gestation and steers born from 
cows on the control diet were randomly assigned to either vaccination using NS (n = 21) (Non – 
supplemented = 10 and supplemented = 11) or using a NF (n = 22) (Non – supplemented = 11 
and supplemented = 11). On d 0 of the trial, both treatment groups received a 2 cc dose of MLV 
BVDV type one and two vaccine with a Mannheimia haemolytica toxoid (Zoetis; 100 Campus 
Drive, Florham Park, New Jersey 07932). The location of vaccination, for both administration 
methods, was subcutaneous on the right side of the neck 10.2 – 12.7 cm behind the ear in the 
anterior angle of the triangular zone. For the NS group, vaccinations were administered with a 
multi – dose pistol – grip syringe fitted with an 18 G 2.54 cm needle. For the NF group, 
vaccinations were administered using a Pulse 250 NeedleFree Injection System (Pulse Needle 
Free System, Lenexa, K. S.), using compressed CO2 set to 310 – 345 kPa. Both treatment 
groups also received a 7 – way clostridial bacterin–toxoid (Zoetis; 100 Campus Drive, Florham 
Park, New Jersey 07932) administered via subcutaneous route on left side of neck. Steers were 
weaned on 150 d of age and transported to the Manitoba Beef and Forage Initiative’s Johnson 
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Farm. All steers were backgrounded on pasture and revaccinated with the same MLV BVDV 
type one and two vaccine with a Mannheimia haemolytica toxoid, using the same 
administration technique and location as the primary dose.  
 Blood samples were collected via jugular venipuncture in the morning on d 0, 2, 5, 7, 
115, and 143 post booster vaccination in 7 ml red top CORVAC serum separation tubes (VWR, 
Radnor, P. A.). Samples were placed on ice for 30 min and centrifuged for 20 min at 1,380 x g 
was pipetted into cryo-vials and frozen at -4° F (-20° C) until later analysis. All serum samples 
in cryo-vials were taken out of freezer and placed in sample tube holders at room temperature 
70° F (21° C) until completed thawed. Subsamples were pipetted into new cryo-vials placed in 
Styrofoam coolers with icepacks and shipped overnight to University of Guelph and Texas 
A&M Veterinary diagnostic lab for Hb and antibody titers, respectively. Serum samples from d 
0, 2, and 7 were sent to the University of Guelph diagnostic lab for Hp concentrations analysis 
using a Roche Cobas 6000 c501 biochemistry analyzer (Makimura and Suzuki, 1982; Skinner et 
al., 1991). Serum samples from day 0, 7, 28, 115 and 143 were sent to Texas A&M Veterinary 
diagnostic lab for BVDV type 2 antibody titers using the serum neutralization test method 
(Mahy and Kangro, 1996).  
            Data were analyzed using the mixed procedure of SAS (SAS Ins. Inc., Cary, N. C.) The 
model included fixed effects of maternal diet, vaccine administration technique, day and their 
interactions with a repeated measure statement for Hp and BVDV type 2. Maternal diet and the 
interaction of maternal diet and vaccine administration technique were not significant so 
maternal diet was removed from the model. Antibody titers were converted using the natural 
log to normalize data. Significance was determined with an alpha of P ≤ 0.05.  
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Results 
 The inflammatory response was observed for both NS and NF treatment groups over 
time (P < 0.001; Figure 3.1). Haptoglobin levels increased d 2 post injection for both NS and 
NF treatment groups (P < 0.001). At d 7 the inflammatory response of the innate immune 
system returned to homeostatic levels observed on d 0. After injection BVDV type 2 antibody 
titers continually declined from d 0, 7, 28, and 115 across both NS and NF treatment groups (P 
< 0.001; Figure 3.2). After secondary booster vaccination on d 115, BVDV type 2 antibody 
titers increased by d 143 (P < 0.001). Bovine viral diarrhea virus type 2 antibody titers after 
primary and secondary vaccination never achieved titer levels seen on d 0 of trial (P < 0.001).   
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Discussion  
 We accept our hypothesis that both NF as well as NS administration of a MLV BVDV 
type one and two vaccine with a Mannheimia haemolytica toxoid will induce a significant 
innate and adaptive immune response which will result in long term immunological memory. 
Long term immunity, shown by antibody and cell-mediated response is detectible after a MLV 
vaccine is administered (Fulton, 2002). The main body of literature that has shown these results 
of long – term humoral and cell – mediated immunity using MLV vaccines has been completed 
using parenteral administration techniques. There are very few research trials that have been 
conducted on MLV BRDC vaccines using NF’s, and to the authors knowledge none of them 
have examined the inflammatory response or the cell mediated response.   
 The inflammatory response was observed for both NS and NF administration 
techniques. One of the most prominent APP found in beef cattle is Hp (Alsemgeest et al., 
1994). Haptoglobin concentrations increase with both bacterial and viral infections (Schroedl et 
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al., 2001; Ganheim et al., 2003; Heegaard et al., 2000; Idoate et al., 2015). Haptoglobin 
concentrations in healthy cattle are often undetected, but during an acute phase response bovine 
Hp can increase 50-100 times (Conner et al., 1988). However, Hp concentrations observed post 
vaccination with killed clostridial 7 – way bacterin toxoids or BRDC 5 – way MLV viral 
vaccines with a Mannheimia haemolytica toxoid have been closer to 4 – 7 fold increases post 
injection (Stokka et al., 1993; Gaspers et al., 2018). The Hp response for both NS and NF 
administration was similar to Stokka et al. (1994) and Gaspers et al. (2018). There was roughly 
a 5 fold increase on d 2 post injection. This peak Hp response to a MLV BRDC viral vaccine on 
d 2 has been shown previously (Gaspers et al., 2018). 
 Antigen specific antibodies have been formally demonstrated as conferring vaccine-
induced protection against many diseases, and the production of memory B cells allows for 
long term disease protection (Casadevall, 2004). MLV vaccines stimulate a rapid immune 
response and generally one dose is needed to stimulate protective immunity (Sutton, 1980; 
Fulton, 2002). One dose will stimulate an adequate immune response, which varies in length 
depending on the form of disease challenge (Fulton, 2002). In the current trial, the immune 
response post primary vaccination was not sufficient enough to induce a humoral response.  
The secondary booster vaccination did induce an improved humoral immune response; 
however, the antibody response on d 143 never reached the antibody titer levels observed on d 
0. The elevated BVDV type 2 antibodies on d 0 is likely the result of maternal antibodies 
derived from colostrum that were absorbed by the calf in the first 12 – 24 h of life (Morein et 
al., 2002).  
 These maternally derived antibodies in circulation of the calf can impede the calf’s own 
immune system to mount an effective response (Morein et al., 2002). This impedance to an 
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effective vaccine response is known as maternal interference (Chase et al., 2008). Maternal 
interference has been demonstrated on several vaccine antigens, including BVDV type 2 (Ellis 
et al., 2001). Thus, the timing of parenteral administered vaccines involves estimating when 
maternal antibody levels have diminished enough for an individual immune response to 
progress sufficiently to provide immunological memory (Chase et al., 2008). In a review, Chase 
et al., (2008) recommended that BVDV control programs that use a MLV should begin around 
2 to 3 mo of age and followed by booster vaccination at around 4 – 5 mo of age. The current 
trial followed that recommendation closely. Based on the antibody levels and lack of response 
to the primary vaccination, initial vaccination of a MLV BVDV virus may have an improved 
vaccine response in calves closer to 3 – 4 mo of age.            
 The majority of cattle vaccines administered to cattle are parenteral, either intramuscular 
or subcutaneous, using a needle and syringe (Babiuk et al., 2018). There are potential 
drawbacks to this vaccine delivery method. Improper handling of needles can result in 
accidental injury to the individual operator as well as the animal receiving vaccine (Weese and 
Jack, 2008). There is also risk that needle fragments may break off during injection and remain 
in the muscle of the animal until slaughter (van Drunen Little-van den Hurk, 2006). 
Additionally, blood – born infectious agents such as bovine leucosis and anaplasmosis as well 
as organism on the skin can be transmitted between animals if one needle is used to inject 
multiple animals (Hollis et al., 2005; Reinbold et al., 2010). These concerns have led to the 
design of alternative vaccination techniques, including the use of NFs (Rey et al., 2013). This 
vaccination technique removes the issues observed with needles, helps reduce disease transfer, 
and reduces vaccination time (Chase et al., 2008; Reinbold et al., 2010; Mousel et al., 2008). 
NF’s do have limitations and drawbacks. At the time of the trial, NF’s were drastically more 
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expensive than a conventional multi – dose syringe and needle. Also, changing the dosage of 
NF’s requires the user to change out the pistons of the NF’s device, which is additional time 
and costs. This vaccination technique has been shown to elicit serological immune responses in 
cattle to Mannheimia haemolytica, IBRV, and BVDV (Hollis et al., 2005; Rey et al., 2013). The 
current study did confirm that the use of NF’s did elicit an inflammatory immune response after 
primary vaccination and a humoral immune response post – secondary vaccination.    
Conclusion  
 The use of NF’s is a viable alternative vaccine administration technique that elicits an 
immune response comparable to traditional parenteral vaccine techniques. As NF’s technology 
advances, costs of NF’s decrease, and the body of research increases, NF devises may become 
more commonplace in the industry. The benefits of this technology are compelling and further 
investigation is warranted. Primary vaccination with a MLV BVDV using either technique on 
calves 60 d of age or less may not result in an adequate humoral immune response due to 
maternal antibodies already in circulation. A secondary vaccination was needed to stimulate the 
immune system enough to increase antibody titers. It is common to vaccinate calves when 
animals are already being handled, such as turnout and weaning. This limits stress to the 
animals and also limits labor required to handle each individual animal. However, it is also 
important to understand how vaccines will interact with the animal’s immune system at 
different time periods in life.       
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CHAPTER 4. EVALUATION OF SEROLOGICAL IMMUNE RESPONSE TO A 
BACTERIAL – PRODUCED PLASMID DNA, ZELNATE, AND A MODIFIED LIVE 
IBRV, BVDV, BRSV, PI3V, AND MANNHEIMIA HAEMOLYTICA VACCINATION ON 
THE FEEDING BEHAVIOR AND FEEDLOT PERFORMANCE OF WEANED 
CALVES 
Abstract  
 The objective was to evaluate the serological immune response to a bacterial – produced 
plasmid DNA, Zelnate, and a modified live IBRV, BVDV, BRSV, PI3V, and Mannheimia 
haemolytica vaccination on the feeding behavior and feedlot performance of weaned calves. 
Weaned commercial Angus and Simmental beef steers (361.5±48.5kg, n=65) were blocked by 
weight and randomly assigned to one of four treatments. Treatment one (T1) was a 2 cc sterile 
saline negative control subcutaneously injected in the neck. Treatment two (T2) was adjuvanted 
MLV IBRV, BVDV (type 1 and 2), BRSV, and PI3V respiratory vaccine combined with M. 
haemolytica bacterin–toxoid administered via subcutaneous route. Treatment three (T3) was 
bacterial – produced plasmid DNA administered the intramuscular route. Treatment four (T4) 
was adjuvanted MLV IBRV, BVDV (type 1 and 2), BRSV, and PI3V respiratory vaccine 
combined with M. haemolytica bacterin–toxoid in combination with bacterial – produced 
plasmid DNA administered via subcutaneous and intramuscular routes, respectively. Blood 
samples were collected via jugular venipuncture in the morning on days 0, 1, 3, 6, and 28 post 
vaccination. Individual feed intake and feeding behavior was monitored using the Insentec 
roughage intake control system.  Haptoglobin (Hp), Interferon gamma (IFNγ), and antibody 
titers for BVDV type 2 were used as a proxy to measure vaccine response. T2 and T4 initiated 
an Hp inflammatory response over time (P < 0.001). Interferon gamma was not significantly 
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different across treatment over time (P = 0.39); however, showed a threefold increase in 
treatment three over time.  T2 and T4 maintained BVDV type 2 antibodies over time (P < 
0.001).  Feed intake and feeding behavior were unaffected by the use of the vaccine and/or 
immunostimulant. 
Introduction  
 The experiences observed through the past two centuries have shown the benefits of 
immunization and that vaccinations are one of the most cost-effective methods to preventing 
economic losses and reduce the risk of disease in livestock (Babiuk, 2002). In livestock, the 
major causes of death preceding slaughter are due to infectious diseases (Babiuk, 2002). Bovine 
respiratory disease complex (BRDC) persists as the single most costly disease syndrome 
associated with commercial beef production in the United States, accounting for losses in 2010 
of 1,055,000 animals valued at $643 million (NASS, 2011). Increased morbidity and mortality, 
decreased weight gains, decreased feed utilization, and decreased carcass quality account for 
the economic losses associated with BRDC (Edwards, 2010). The morbidity risk of BRDC in 
feedlot cattle occurs in the first 45 d after arrival into the feedlot with the highest risk occuring 
in wk 1 to 3, after that morbidity declines (Buhman et al., 2000; Edwards, 1996). 
 To help combat this costly inefficiency, cattle producers have implemented vaccination 
protocols for their beef herds. The viral vaccine components of BRDC consist of bovine 
herpesvirus type 1, also known as infectious bovine rhinotracheitis (IBRV), bovine viral 
diarrhea virus (BVDV), parainfluenza virus type 3 (PI-3V), and bovine respiratory syncytial 
virus (BRSV) (Urban-Chmiel and Grooms, 2012). The bacterial vaccine components of BRDC 
consists of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni (Urban-
Chmiel and Grooms, 2012). Killed and modified live vaccines (MLV) are available in different 
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combinations of viral pathogens (Urban-Chmiel and Grooms, 2012). The appropriate use of 
these vaccines can reduce the risk of BRDC (Urban-Chmiel and Grooms, 2012). Disease 
control or elimination requires the stimulation of the immune system in a sufficient proportion 
of the population or herd (Siegrist, 2013). Immunization is achieved by inducing protection, as 
a result of stimulating the adaptive immune system (Siegrist, 2013). However, exposing an 
animal to an antigen can negatively affect their performance in the feedlot (Stokka et al., 1994). 
This immunity is achieved by the maintenance of antigen-specific immune effectors and/or by 
the induction of immune memory cells that can reactivate if re-exposure to the antigen occurs 
(Siegrist, 2013). 
 In order to elicit a vaccine response, a vaccine must provide enough danger signals from 
the antigen, typically paired with an adjuvant, to trigger the inflammatory reaction that is 
mediated by cells of the innate immune system (Hoebe et al., 2004). Upon injection of vaccine 
antigens, an acute phase inflammation develops within minutes (Tizard, 2013). Upon injection 
of an antigen, broken cells release molecules known as damage-associated molecular patterns 
(DAMPs) that trigger the release of cytokines, chemokines, and enzymes from sentinel cells 
(Tizard, 2013). The antigens also provide pathogen-associated molecular patterns (PAMPs) that 
trigger sentinel cell response (Tizard, 2013). This causes the sentinel cells to synthesize and 
secrete a mixture of molecules that trigger inflammation and initiates the first steps of the 
adaptive immune system (Tizard, 2013). The three major cytokines secreted by sentinel cells 
include tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6) (Tizard, 
2013). 
 The release of TNF-α, IL-1, and IL-6 increases protein synthesis, specifically acute 
phase proteins (APP) (Tizard, 2013). APP are a group of blood proteins that change in 
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concentration when an animal is subjected to external or internal challenges, such as infection, 
inflammation, and stress (Murata et al., 2004). One of the most prominent APP found in beef 
cattle is haptoglobin (Hp) (Alsemgeest et al., 1994). Hp concentrations in healthy cattle are 
often undetected, but during an acute phase response bovine haptoglobin can increase 50-100 
times (Conner et al., 1988). However, Hp concentrations observed post vaccination with killed 
clostridial 7 – way bacterin toxoids or BRDC 5 – way MLV viral vaccines with a Mannheimia 
haemolytica toxoid have been closer to 4 – 7 fold increases post injection (Stokka et al., 1993; 
Gaspers et al., 2018). Hp concentrations will increase with both bacterial and viral infections 
(Schroedl et al., 2001; Ganheim et al., 2003; Heegaard et al., 2000; Idoate et al., 2015), and Hp 
can be used as a tool to measure respiratory disease in feedlot conditions (Idoate et al., 2015). 
 Inflammation and the actions of the innate immune system may be sufficient to protect 
the body, but it cannot be guaranteed to provide complete resistance to infection, or assist the 
body to learn from the experience (Tizard, 2013). This limitation of the innate immune response 
is the advantage of the adaptive immune response (Tizard, 2013). Dendritic cells are the link 
between the innate and adaptive immune system. When exposed to an antigen, dendritic cells 
undergo a maturation process, modulating specific surface receptors and migrate towards the 
lymphatic system, in secondary lymph nodes (Siegrist, 2013). Phagocytosed antigen is loaded 
onto the MHC class II molecules and presented to T cells (Tizard, 2013). The central role of 
dendritic cells, in response to a vaccine, is to provide antigen-specific and costimulatory signals 
to activate naïve T cells (Palucka et al., 2005). 
 The MHC-peptide complex is displayed on the surface dendritic cells and binds to a 
subset of CD4+ T cells, follicular helper T cells (Siegrist, 2013). These follicular helper T cells 
have different sets of chemokine receptors, transcription factors, surface markers, and 
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interleukins that are uniquely equipped to provide the most efficient B cell help through a series 
of costimulatory molecules (Vinuesa et al., 2005). The interactions between antigen-specific 
germinal center B cells, antigen bearing follicular dendritic cells, and follicular helper T cells 
results in the production of B cells with the highest level of antigen-specific affinity (Siegrist, 
2013). This combination provides signals necessary for the differentiation of germinal center B 
cells either towards plasma secreting specific antibodies or towards memory B cells (Siegrist, 
2013). Antigen specific antibodies have been formally demonstrated as conferring vaccine-
induced protection against many diseases, and the production of memory B cells allows for the 
long term disease protection (Casadevall, 2004). 
 In addition to vaccination for the bacterial and viral components to reduce the incidence 
of BRDC, the prophylactic use of antibiotics has been commonly used in United States beef 
production to control BRDC (Panciero and Confer, 2010; Murray et al., 2016). With increasing 
public concerns about widespread use of antimicrobials and governmental policy regarding the 
use of antimicrobials, alternative preventative treatments have been investigated (Ilg, 2017). 
Activation of specific areas of the immune system in cattle has been considered as a potential 
mechanism and area of research (Ackermann et al., 2010). Administration of an exogenous 
substances that has the ability to augment and/or stimulate certain immune responses may have 
the ability to increase disease resistance (Blecha, 1988). Substances that exert these functions 
are known as immunostimulants (Blecha, 2001). The ability to enhance or initiate an immune 
response to benefit the animal and thus the production efficiency is the goal of 
immunostimulation in food producing animals (Hudson, 2017). This concept has raised interest 
in the beef industry as a potential novel preventative measure that may be reduce antimicrobial 
use (Hudson, 2017). There are a limited number of immunostimulatory products that have been 
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licensed by the United States Department of Agriculture for use in food animals and few have 
achieved Food and Drug Administration approval (Huenefeld, 1988; Blecha, 2001).  
 The first, and only, immunostimulant on the market approved for the aid in treatment of 
BRDC in beef cattle is Zelnate (Ilg, 2017).  Research completed by Bayer (2014) showed a 
reduction in lung lesions and mortality associate with BRDC. Zelnate is a plasmid DNA rich in 
non – methylated CpG motifs that is encased in a cationic liposome shell (Ilg, 2017). Zelnate is 
indicated for use to reduce the incidence of BRDC caused by Mannheimia haemolytica in cattle 
4 mo of age or older, when administered at the time of or within 24 h of a perceived stressful 
event (Nickell et al., 2016). Ilg (2017) researched Zelnate’s potential mechanism of action by 
investigating cellular DNA recognition pathways in cell culture using knockout human and 
mouse cell lines and reporter gene assays. Ilg (2017) reported that Zelnate, despite being rich in 
CpG islands, did not activate TLR9 and the downstream proinflammatory NFКB pathway. Ilg 
(2017) did report that Zelnate did initiate the IRF3 pathway, known to lead to a strong type I 
interferon response. Rogers et al. (2017) evaluated health outcomes of at risk heifers for the first 
60 d upon arrival to the feedlot. Rogers et al., (2017) did not report differences among treatment 
groups on the incidence of heifers treated for respiratory disease; however, the inclusion of 
Zelnate did reduce the percentage of BRDC associated morbidity as well as overall mortality by 
d 60. Roger et al. (2017) reduced morality results correspond with the results reported by Bayer 
(2014), which may suggest that the DNA immunostimulant has the potential to positively affect 
survivability and health outcomes of high risk feedlot calves.  
 The objective of this study is to evaluate the serological immune response to a bacterial 
– produced plasmid DNA, Zelnate, and a modified live IBRV, BVDV, BRSV, PI3V, and 
Mannheimia haemolytica vaccination on the feeding behavior and feedlot performance of 
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weaned calves. We hypothesized that the bacterial – produced plasmid DNA, Zelnate, and a 
modified live IBRV, BVDV, BRSV, PI3V, and Mannheimia haemolytica vaccination will 
initiate an immune response to previously vaccinated, newly weaned, backgrounding steers and 
will not have an effect on feeding behavior and feedlot performance.   
Materials and Methods 
 All procedures were approved by the North Dakota State University Animal Care and 
Use Committee. This study utilized 65 weaned commercial Angus and Simmental beef steers 
(361.5±48.5kg) born (January. 1, 2015, to March 31, 2015). At birth, calves were vaccinated 
with MLV IBRV, PI3V, and BRSV (Zoetis; 100 Campus Drive, Florham Park, New Jersey 
07932) administered via intranasal route and a killed clostridial type C and D bacterin –toxoid 
(Zoetis; 100 Campus Drive, Florham Park, New Jersey 07932) administered via subcutaneous 
route. On 1 April 2015, calves were vaccinated with an adjuvanted MLV IBRV, BVDV (type 1 
and 2), BRSV, and PI3V respiratory vaccine combined with M. haemolytica bacterin-toxoid 
(Zoetis; 100 Campus Drive, Florham Park, New Jersey 07932), a 7 – way clostridial bacterin–
toxoid (Zoetis; 100 Campus Drive, Florham Park, New Jersey 07932) administered via 
subcutaneous route and received the macrocyclic lactone, doramectin (Zoetis; 100 Campus 
Drive, Florham Park, New Jersey 07932) administered topically. On 1 September 2015, calves 
received a MLV IBRV, BVDV (type 1 and 2) PI3V, and BRSV vaccine combined with 
Campylobacter - Leptospira bacterin (Zoetis; 100 Campus Drive, Florham Park, New Jersey 
07932) and a killed Cl. chauvoei, Cl. septicum, Cl. novyi, Cl. sordelli, Cl. perfringens (types C 
and D) and M. haemolytica type A1 (Zoetis; 100 Campus Drive, Florham Park, New Jersey 
07932) subcutaneously and received the macrocyclic lactone, doramectin (Zoetis; 100 Campus 
Drive, Florham Park, New Jersey 07932) administered topically. Calves were weaned for 30 d 
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and then shipped to the NDSU’s Beef Cattle Research Complex. Upon arrival on 15 October 
2015, calves (n = 65, body weight [BW] = 336.1 ± 31.6 kg) were trained for 21 d to the 
Insentec Roughage Feeders (Insentec; Insentec B. V. Repelweg 10, 8316 PV Marknesse, 
Netherlands).  
 Insentec Roughage Feeders measure dry matter intake (DMI) kg, time spent at feeder 
measured in minutes and number of visits, and the number of meals can be calculated. Body 
weight kg was determined on d -21, 0, 1, 3, 6, 28, and 29 and average daily gain (ADG), feed 
conversion ratio (FCR), and gain-to-feed (G:F) were calculated. Time spent at feeder, number 
of visits, and meals were calculated on a 24-h cycle. A meal is defined as a distinct, separate 
eating period and visit not separated by intervals longer than seven minutes (Forbes, 1995; 
Montanholi et al., 2010). 
 On d 0, calves were blocked by weight, randomly assigned to one of four possible 
treatments. Treatment one (T1) was a 2 cc sterile saline negative control subcutaneously 
injected in the neck. Treatment two (T2) was a 2 cc adjuvanted MLV IBRV, BVDV (type 1 and 
2), BRSV, and PI3V respiratory vaccine combined with M. haemolytica bacterin–toxoid 
(Zoetis; 100 Campus Drive, Florham Park, New Jersey 07932) administered via the 
subcutaneous route. Treatment three (T3) was bacterial – produced plasmid DNA (Bayer; 100 
Bayer Boulevard, Whippany, New Jersey 07981) administered via the intramuscular route. 
Treatment four (T4) was adjuvanted MLV IBRV, BVDV (type 1 and 2), BRSV, and PI3V 
respiratory vaccine combined with M. haemolytica bacterin–toxoid in combination with 
bacterial – produced plasmid DNA  administered via the subcutaneous and intramuscular 
routes, respectively. Blood samples were collected via jugular venipuncture in the morning on 
days 0, 1, 3, 6, and 28 post vaccination in 7 ml red top CORVAC serum separation tubes 
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(VWR, 100 Matsonford Road, Radnor, Pennsylvania, 19087). Samples were placed on ice for 
30 min and centrifuged for 20 min at 1,380 x g to separate serum, which was then pipetted into 
cryo-vials and frozen at -20° C until later analysis. All serum samples in cryo-vials were taken 
out of freezer and placed in sample tube holders at room temperature (21° C) until completed 
thawed. Subsamples were pipetted into new cryo-vials placed in Styrofoam coolers with 
icepacks and shipped overnight to University of Guelph and Texas A&M Veterinary diagnostic 
lab for Hp and antibody titers, respectively. Serum samples from d 0, 1, 3, and 6 were sent to 
the University of Guelph diagnostic lab for Hp concentrations analysis using a Roche Cobas 
6000 c501 biochemistry analyzer (Makimura and Suzuki, 1982; Skinner et al., 1991). Serum 
samples from d 0, 6, and 28 were sent to Texas A&M Veterinary diagnostic lab for BVDV type 
2 antibody titer using the serum neutralization test method (Mahy and Kangro, 1996).  
 Serum samples from d 0, 1, 3, and 6 were analyzed for interferon gamma (IFNγ) using 
commercially available enzyme – linked immunosorbent assay (ELISA) kit (ABclonal; 86 
Cummings Par Drive, Woburn, Massachusetts, 01801) according to the protocol supplied by 
the manufacturer. Serum was diluted four fold with phosphate buffered saline. Standards, 
pooled controls, and diluted sample unknowns were added in triplicate to pre – blocked 96 well 
plate. Optical density (OD) readings at a wavelength of 450 nm were obtained with a Synergy 
H1 Microplate Reader (Biotek; 100 Tigan Street, Winooski, Vermont, 05404). A standard curve 
(R2 ≤ .992) was produced for each plate which transformed the mean OD values of each sample 
to the quantity of IFNγ in pg/ml (CV ≥ 7.5%).      
 Data were analyzed using the mixed procedure of SAS (SAS Ins. Inc., Cary, N. C.) The 
model included fixed effects of treatment, day, breed and their interactions with a repeated 
measure statement for Hp, IFNγ, and BVDV type 2 antibody titers. Antibody titers were 
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converted using the natural log to normalize data. Significance was determined with an alpha of 
P ≤ 0.05.  
Results 
 The inflammatory response upon injection was observed for both T2 and T4. Both 
treatments contained the adjuvanted MLV IBRV, BVDV (type 1 and 2), BRSV, and PI3V 
respiratory vaccine combined with M. haemolytica bacterin–toxoid (P < 0.001; Figure 4.1.). Hp 
levels increased beginning at 1 d post injection (P < 0.001) and peak response occurred 3 d post 
injection (P < 0.001). By d 6, Hp levels declined and returned to levels observed on d 0. IFNγ 
was not different across treatment over time (P = 0.39; Figure 4.2.). Serum BVDV type 2 
antibody titers levels were greatest for T1, T2, T3, and T4 on d 0 (P < 0.001; Figure 4.3.). All 
BVDV type 2 antibody titer levels decreased by d 6 (P < 0.001). By d 28 only T2 and T4 
BVDV type 2 antibody titers increased to reach values observed on d 0 (P < 0.001). Breed was 
included in the statistics model for all variables. There were no interactions with breed and 
treatment across time. Breed did not significantly affect Hp or IFNγ response. Breed was 
significant on BVDV type 2 antibody titers (P = 0.008) where commercial Angus steers had 
increased titers compared to Simmental steers (4.1 vs. 3.2 ± 0.2). All variables used to quantify 
feeding behavior and growth performance were not significantly different between all four 
treatment groups (Tables 4.1. and 4.2.).    
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Table 4.1. Influence of bacterial - produced plasmid DNA and MLV 
IBRV, BVDV, BRSV, PI3, and Mannheimia haemolytica on feeding 
behavior in backgrounding steers. 
 
Treatmenta 
  
Item  1 2 3 4 SEMb P Value 
DMI, kg 8.21 8.30 8.62 8.48 0.27 0.67 
Eating       
events, no./d       
   Visits 23.9 28.9 29.7 26.1 2.5 0.35 
   Meals/d 10.1 10.5 10.9 9.9 0.83 0.54 
Eating time,       
min       
   Per visit 6.82 7.17 5.74 7.24 0.55 0.21 
   Per meal 16.3 17.5 15.2 18.2 1.2 0.25 
   Per day 157 171 161 173 5.8 0.15 
Feed DMI, kg       
   Per visit 0.36 0.34 0.31 0.36 0.03 0.47 
   Per meal 0.86 0.84 0.81 0.91 0.06 0.77 
   Per min 0.05 0.05 0.05 0.05 0.001 0.06 
a1: Sterile saline, 2: Adjuvanted MLV IBRV, BVDV (type 1 and 2), 
BRSV, and PI3V respiratory vaccine combined with M. haemolytica 
bacterin–toxoid, 3: bacterial – produced plasmid DNA, 4: Adjuvanted 
MLV IBRV, BVDV (type 1 and 2), BRSV, and PI3V respiratory 
vaccine combined with M. haemolytica bacterin–toxoid + bacterial – 
produced plasmid DNA 
bStandard error of the mean (n = 65).    
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Table 4.2. Influence of bacterial - produced plasmid DNA and MLV 
IBRV, BVDV, BRSV, PI3, and Mannheimia haemolytica on growth 
performance in backgrounding steers.   
 
Treatmenta 
  
Item  1 2 3 4 SEMb P Value 
Initial BW, kg  364 355 360 362 9.02 0.89 
Final BW, kg 389 384 387 392 9.93 0.95 
Gain, kg 24.7 29.1 27.4 29.4 2.82 0.62 
Weight change       
   3 day 0.56 5.49 2.27 2.32 2.01 0.38 
   6 day 1.64 5.91 1.84 2.59 1.75 0.29 
ADGc 0.88 1.04 0.98 1.05 0.1 0.62 
G:F 0.05 0.05 0.05 0.05 0.005 0.47 
a1: Sterile saline, 2: Adjuvanted MLV IBRV, BVDV (type 1 and 2), 
BRSV, and PI3V respiratory vaccine combined with M. haemolytica 
bacterin–toxoid, 3: bacterial – produced plasmid DNA, 4: Adjuvanted 
MLV IBRV, BVDV (type 1 and 2), BRSV, and PI3V respiratory 
vaccine combined with M. haemolytica bacterin–toxoid + bacterial – 
produced plasmid DNA    
bStandard error of the mean (n = 65).     
cCalculated by dividing the total gain calculated from the average initial 
and final weights by 28 days 
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Discussion  
 We accept our hypothesis that the bacterial – produced plasmid DNA, Zelnate, and a 
modified live IBRV, BVDV, BRSV, PI3V, and Mannheimia haemolytica vaccination will 
initiate an immune response to previously vaccinated, newly weaned, backgrounding steers and 
will not have an effect on feeding behavior and feedlot performance. Throughout the trial there 
were no negative effects on feeding behavior or feedlot performance. Also, after completion of 
the trial and backgrounding phase, we did not observe any signs of respiratory disease leading 
up to finishing weights and slaughter.   
 The inflammatory response was observed in both treatment groups that contained an 
adjuvanted MLV IBRV, BVDV (type 1 and 2), BRSV, and PI3V respiratory vaccine combined 
with M. haemolytica bacterin–toxoid. One of the most prominent APP found in beef cattle is 
Hp (Alsemgeest et al., 1994). Hp concentrations will increase with both bacterial and viral 
infections (Schroedl et al., 2001; Ganheim et al., 2003; Heegaard et al., 2000; Idoate et al., 
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Figure 4.3. BVDV type 2 antibody titers by vaccination treatment across time  
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2015). T1 (sterile saline) and T3 (bacterial – produced plasmid DNA) did not initiate an Hp 
inflammatory response. Hp concentrations observed post vaccination with killed clostridial 7 – 
way bacterin toxoids or multivalent MLV viral vaccines with a Mannheimia haemolytica toxoid 
have been closer to 4 – 7 fold increases post injection (Stokka et al., 1993; Gaspers et al., 2018). 
The Hp response for both T2 and T4 administration was similar to Stokka et al. (1993) and 
Gaspers et al. (2018). There was roughly a 5 fold increase on d 3 post injection. This peak Hp 
response to a MLV BRDC viral vaccine on d 3 has been shown previously (Gaspers et al., 
2018). 
 BRDC is typically initiated with infection of viral pathogens that can predispose the 
animal to a secondary bacterial infection (Rice et al., 2007). The ability of the bacterial – 
produced plasmid DNA immunostimulant to activate the innate immune system towards a viral 
pathogen could prove beneficial in preventing BRDC. Ilg (2017) did report that Zelnate did 
initiate the IRF3 pathway, known to lead to a strong type I interferon response in human and 
mouse cell culture. Type I interferons are a major effector cytokine of the host immune 
response against viral pathogens (Gonzalez – Navajas et al. 2012). Type II interferon, IFNγ, 
also exhibits antiviral activities ((Gonzalez – Navajas et al. 2012). In addition to antiviral 
activity, IFNγ plays a major role in the cell mediate immune (CMI) response (Siegrist, 2013). 
The CMI response initiates CD8+ cytotoxic T cells, bind to virally infected cells and initiate 
apoptosis directly by release of perforin and granzyme and indirectly thorough antimicrobial 
cytokine release (Siegrist, 2013). Though IFNγ was not significantly different across treatment 
over time, further investigation is warranted.  
 Antigen specific antibodies have been formally demonstrated as conferring vaccine-
induced protection against many disease, and the production of memory B cells allows for the 
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long term disease protection (Casadevall, 2004). MLV vaccines stimulate a rapid immune 
response and generally one dose is needed to stimulate protective immunity (Sutton, 1980; 
Fulton, 2002). One dose will stimulate an adequate immune response, which varies in length 
depending on the form of disease challenge (Fulton, 2002). In the current trial, the humoral 
immune response post vaccination to an adjuvanted MLV IBRV, BVDV (type 1 and 2), BRSV, 
and PI3V respiratory vaccine combined with M. haemolytica bacterin–toxoid did not result in 
an increase to BVDV type 2 antibody titers. Compared to T1 and T3 on d 28, T2 and T4 did 
maintain an elevated level of BVDV type antibody titers seen on d 0 of the trial. This elevated 
BVDV type 2 antibody titers seen at the beginning of the trial may have been due to previous 
vaccinations of steers before the trial. These steers had been exposed to a MLV BVDV antigens 
twice before this trial, with the last exposure 30 d before the trial start date. This could be the 
reason for the elevated BVDV type 2 antibody titers seen on d 0. The breed effect on BVDV 
type 2 antibody titers could be due to heterozygote advantage of MHC polymorphisms (Tizard, 
2013). This means that MHC heterozygotes are at an advantage because they can respond to a 
much larger range of antigens and are better suited to survive infectious diseases (Tizard, 2013). 
The cattle used on this trial came from a closed NDSU herd. The herd consists of registered 
Angus, registered Simmentals and commercial SimAngus cattle. The two groups used in this 
trial were registered Simmental and commercial SimAngus cows with 75% or greater Angus 
genetics. This could shed some light as to the increased BVDV type 2 antibody titers seen in the 
commercial SimAngus steer calves. Genetic differences on immune response to vaccine 
antigens was not the focus of this research and further investigation is warranted to examine the 
heterozygote advantage of cross – bred calves on immune response to vaccine antigens as well 
as morbidity and mortality of BRDC.      
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 In addition to vaccination for the bacterial and viral components to reduce the incidence 
of BRDC, the prophylactic use of antibiotics has been commonly used in United States beef 
production to control BRDC (Panciero and Confer, 2010; Murray et al., 2016). With increasing 
public concerns about widespread use of antimicrobials and governmental policy regarding the 
use of antimicrobials, alternative preventative treatments have been investigated (Ilg, 2017). 
Activation of specific areas of the immune system in cattle has been considered as a potential 
mechanism and area of research (Ackermann et al., 2010). Administration of an exogenous 
substances that has the ability to augment and/or stimulate certain immune responses may have 
the ability to increase disease resistance (Blecha, 1988). The ability to enhance or initiate an 
immune response to benefit the animal and thus the production efficiency is the goal of 
immunostimulation in food producing animals (Hudson, 2017). This concept has raised interest 
in the beef industry as a potential novel preventative measure that may reduce antimicrobial use 
(Hudson, 2017). There are a limited number of immunostimulatory products that have been 
licensed by the United States Department of Agriculture for use in food animals and few have 
achieved Food and Drug Administration approval (Huenefeld, 1988; Blecha, 2001). 
Conclusion   
 Public concerns about animal agriculture and the widespread use of antimicrobials are 
not going to go away. Even with improved vaccines and increased number of cattle that are 
vaccinated prior to weaning and transport, BRDC continues to plague the beef industry. The 
ability to utilize an exogenous immunostimulant that boost the calf’s own immune system in 
addition to low stress handling techniques, proper vaccination techniques, and management 
strategies may be beneficial to help reduce the incidence of BRDC and the use of 
antimicrobials.   
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 Calves used in this study were exposed to BVDV vaccine antigens two times prior to 
the study, from the same heard, and were allowed to acclimate to their new environment for 21 
d before the start of this study. Results on high stress animals that are weaned, vaccinated and 
comingled with calves from different herds may be different. Further research is needed to 
evaluate unvaccinated, immune-naïve, calves that are weaned and brought together in a 
backgrounding feedlot environment.   
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CHAPTER 5. GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 The passive immune transfer is critical to immediate survival of the calf. Colostrum 
absorption is one of the most important factors in shaping calf health. Calves that fail to absorb 
enough Ig in colostrum have high pre-weaning mortality rates, up to 89 % in the first week of 
life (McGuire et al., 1976), as well as other short-term and long-term losses related to animal 
health, welfare, and productivity (Godden 2008). The continued health of the animal is 
paramount to long term productivity. In livestock, the major causes of death preceding slaughter 
are due to infectious diseases (Babiuk, 2002). Bovine respiratory disease complex (BRDC) 
persists as the single costliest disease syndrome associated with commercial beef production in 
the United States, accounting for losses in 2010 of 1,055,000 animals valued at $643 million 
dollars (NASS, 2011). Increased morbidity and mortality, decreased weight gains, decreased 
feed utilization, and decreased carcass quality account for the economic losses associated with 
BRD (Edwards, 2010). It is apparent that health in beef calves from birth to weaning is critical 
to a more efficiently industry. The beef industry is under constant pressure to produce a product 
that is cost effective, nutritious, and humane. It is our job as researchers and stewards of these 
livestock species to promote health and productivity.  
 Chapter two discussed the effects of starch supplementation to beef cows on colostrum 
production, offspring birth weight, incidence of dystocia, respiratory acidosis, and the passive 
transfer of immunity. Briefly, colostrum Brix % tended to be greater in SUP dams compared to 
CON dams (25.10 vs. 21.77 ±1.17%; P = 0.056).  Incidence of dystocia, as measured by 
calving ease score, was not different across maternal dietary treatment groups. Calf activity post 
– partum, as measured by calf vigor score, was not significantly different across treatment 
groups. Again, similar to calving ease score, there was very little variation in this variable, 
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which could strengthen the fact that incidence of dystocia was not observed in this trial. All 
blood gas parameters used to quantify metabolic and respiratory acidosis were not different 
between maternal dietary treatment groups. Ranges for venous blood pH, pCO2, pO2, HCO3, 
and base excess were all within normal ranges at 0 h. Ranges for venous blood pCO2, pO2, 
HCO3, and base excess were all within normal ranges at 24 h. Worth noting is that pH in 
venous blood at 24 h for calves born to CON dams 7.01, which is considered acidotic. Calves 
with inadequate serum IgG concentrations (<8 mg/ml) at 24 h are from 3.2 to 9.5 times more 
likely to become sick and 5.4 times more likely to die before weaning compared to calves with 
adequate concentrations of serum IgG (>16 mg/ml). When calves have inadequate serum IgG 
concentrations (<8 mg/ml) a failure of passive transfer (FPT) of immunity has occurred. Calves 
born from CON and SUP dams had 24 h serum IgG levels three times the 16 mg/ml the 
threshold for an adequate immune transfer. Calves born from CON and SUP dams had 24 h 
serum protein levels that exceed the <5.2 g/dl, which is also attributed to a FPT at 24 h. 
 Chapter three discussed the evaluation of the needle – free injection device (NF) on 
serological innate and adaptive immune responses to a MLV BVDV type 1 and 2 vaccine with 
a Mannheimia haemolytica toxoid. Maternal diet did not significantly effect on Hp (P = 0.78) 
or BVDV type 2 antibody titers (P = 0.23). The inflammatory response was observed for both 
NS and NF treatment groups (P < 0.001). After injection BVDV type 2 antibody titers 
continually declined from d 0, 7, 28, and 115 across both NS and NF treatment groups (P < 
0.001). After secondary booster vaccination on d 115, BVDV type 2 antibody titers 
significantly increased by d 143 (P < 0.001).   
 Finally, chapter four discussed the serological immune response to a bacterial – 
produced plasmid DNA, Zelnate, and a modified live IBRV, BVDV, BRSV, PI3V, and 
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Mannheimia haemolytica vaccination on feeding behavior and feedlot performance of weaned 
calves. Treatments two and four initiated an Hp inflammatory response over time (P<0.001). 
Interferon gamma was not significantly different across treatment over time (P = 0.39).  
Treatments two and four maintained BVDV type 2 antibodies over time (P <0.001).  Feed 
intake and feeding behavior were unaffected by the use of the vaccine and/or immunostimulant. 
 No animal study is without limitations and short comings, and there is certainly room 
for improvement if these trials were to be repeated. A solution to obtaining more accurate 
results in trials from chapter two would be to increase the number of animals as well as 
observations – this would certainly aid in better understanding the passive transfer of immunity 
and factors that influence it. Integrating corn into the TMR instead of putting it into its own 
Insentec bunk may have limited the forage substitution effects seen in chapter two. Also, 
increasing the starch supplementation above 0.2% of BW may have also increased weight and 
BCS differences at the time of parturition. The continued use of physiologic markers in addition 
to categorical variables is very important. The use of lactate, base excess, pH, pCO2, pO2, Base 
Excess, HCO3, TCO2, sO2, and lactate assisted in monitoring and quantifying fetal asphyxia and 
incidence of dystocia. The next step for chapter two would be to examine a wider array of 
immune factors in the colostrum as well calf sera. The research in chapter four had a large 
enough number of animals to effectively look at the vaccination response. That trial does have 
its limitations as well. The steers used in that trial were all previously vaccinated multiple times 
and were all from the same herd. A similar trial on immune-naïve calves from multiple herds 
may not respond in the same manner. The stresses of weaning and comingling may depress the 
immune system and being exposed to a vaccine antigen and/or immunostimulant may 
negatively affect feeding behavior and feedlot performance. A sex affect was also not 
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determined in this vaccine trial. Heifers in a similar trial may not react in the same manner. The 
immune response for the bacterial – produced plasmid DNA was not clearly defined. The IFNγ 
results for the bacterial – produced plasmid DNA leaves a lot to be desired. Looking at more 
cytokine profiles over increased number of days beyond six may help elucidate the 
immunostimulants specific mode of action. 
 These projects have prospective uses both for future research as well as a benefit to the 
livestock industry, particularly for those in cow-calf and backgrounding operations. The 
majority of more recent colostrum research has focused around the dairy calf. There have been 
very few research trials examining nutrient supplementation of the dam and effects on neonatal 
calf health. The vast majority of research has looked at maternal nutrient restriction and effects 
on calf health. Much of that data is decades old and it is important to continue updating the 
body literature using cattle genetics in current production beef herds. The human and animal 
welfare benefits of NF’s technology are compelling and further investigation is warranted. As 
NF technology advances, costs of NF’s decrease, and the body of research increases, NF 
devises may become more commonplace in the industry. Public concerns about animal 
agriculture and the widespread use of antimicrobials are not going to go away. Even with 
improved vaccines and increased number of cattle that are vaccinated prior to weaning and 
transport, BRDC continues to plague the beef industry. The ability to utilize an exogenous 
immunostimulant that boost the calf’s own immune system in addition to low stress handling 
techniques, proper vaccination techniques, and management strategies may be beneficial to help 
reduce the incidence of BRDC and the use of antimicrobials. The ability to design precise 
feeding programs during late gestation to help the calf transition healthily into extra-uterine life 
as well as assist in thorough vaccination and immunostimulant regimes that will keep calves 
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immunologically sound to progress into the next phases of life while decreasing the use of 
antimicrobials is of importance to the long-term sustainability of the beef industry.  
 
